<?xml version="1.0" encoding="UTF-8"?><html xmlns:tei="http://www.tei-c.org/ns/1.0" xmlns:voice="http://www.univie.ac.at/voice/ns/1.0" xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cq="http://www.univie.ac.at/voice/corpusquery" xmlns:exist="http://exist.sourceforge.net/NS/exist">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>PRpan585: Panel discussion on preventing seizures in temporal lobe epilepsy</title>
      <link type="text/css" rel="stylesheet" href="view_transcript.css" /><script language="Javascript" type="text/javascript" src="prototype.js">//</script><script language="Javascript" type="text/javascript">
        function toggleClass(cls){
        $$('.' + cls).invoke('toggle');
        }
      </script></head>
   <body>
      <div id="style_switches" class="switches"><span class="switch sw_line_no" onclick="toggleClass('line_no');" title="utterance identifier">1</span><span class="switch sw_sid" onclick="toggleClass('sid');" title="Speaker id">S1:</span><span class="switch   sw_overlap_tag" onclick="toggleClass('overlap_tag');" title="overlap tags">&lt;1&gt;</span><span class="switch   sw_pause" onclick="toggleClass('pause');" title="pauses">(.)</span><span class="switch   sw_contextual_event" onclick="toggleClass('contextual_event');" title="contextual events">{...}</span><span class="switch sw_smode" onclick="toggleClass('smode');" title="speaking modes">&lt;fast&gt;</span><span class="switch sw_vocal" onclick="toggleClass('vocal');" title="vocal/speaker noise">&lt;coughs&gt;</span><span class="switch sw_spel" onclick="toggleClass('spel_tag');" title="spelled">&lt;spel&gt;</span><span class="switch sw_foreign_tag" onclick="toggleClass('foreign_tag');" title="foreign language tags">&lt;L1fr&gt;</span><span class="switch        sw_other_continuation" onclick="toggleClass('other_continuation');" title="other continuations">=</span><span class="switch sw_un_tag" onclick="toggleClass('un_tag');" title="unintelligible tags">&lt;un&gt;</span><span class="switch sw_ono_tag" onclick="toggleClass('ono_tag');" title="onomatopoeia">&lt;ono&gt;</span><span class="switch sw_pvc_tag" onclick="toggleClass('pvc_tag');" title="pvc tags">&lt;pvc&gt;</span><span class="switch sw_gap" onclick="toggleClass('gap');" title="gap">(gap/(nrec</span></div>
      <div class="title">
         <h1>Text:
            
         </h1>
         <h2>Panel discussion on preventing seizures in temporal lobe epilepsy</h2>
      </div>
      <div class="text">
         
         
         
         <div class="u " id="PRpan585_u_1"><span class="line_no">PRpan585:1</span><span class="sid " id="src_PRpan585_u_1_PRpan585_S1">S1: </span><span class="utext"> okay i think we can start <span class="pause"> (3) </span> good afternoon everybody <span class="pause"> (.) </span> welcome to our <span class="pause"> (.) </span> session <span class="pause"> (.) </span> there are several sessions so  (as to)  be er high contribution among the sessions so <span class="pause"> (.) </span> we want to thank to  all of you <span class="pause"> (.) </span> that you choose us i hope <span class="pause"> (.) </span> you were not frustrated at the end because <span class="pause"> (.) </span> er this is such a topic that <span class="pause"> (.) </span> really i am not sure that if we will have find some answers at the end of of the session <span class="pause"> (.) </span> as i am a  (cognition)  i am always hopeless when i see a patient with <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis and temporal lobe epilepsy <span class="pause"> (.) </span> coming to my clinic with all these refractory seizures with depression and lot of social problems <span class="pause"> (.) </span> also there are several papers erm which have been published since eighties on this er topic especially on <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis we still have don't have a medical drug <span class="pause"> (.) </span> to stop the seizures we s:till have <span class="pause"> (.) </span><span class="emph"> NOTHING </span> to prevent <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in the meantime <span class="pause"> (3) </span> just to introduce the situation to you briefly i know that you all know about the station but <span class="pause"> (.) </span><span class="to_tag">&lt;to S2&gt;</span><span class="smode">&lt;soft&gt;</span> we can <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> i can <span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S2&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_2"><span class="line_no">PRpan585:2</span><span class="sid " id="src_PRpan585_u_2_PRpan585_S2">S2: </span><span class="utext"><span class="to_tag">&lt;to S1&gt;</span><span class="smode">&lt;soft&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap"><span class="overlap_tag">&lt;1&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap_tag 1">&lt;/1&gt;</span></span><span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S1&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_3"><span class="line_no">PRpan585:3</span><span class="sid " id="src_PRpan585_u_3_PRpan585_S1">S1: </span><span class="utext"><span class="to_tag">&lt;to S2&gt;</span><span class="smode">&lt;soft&gt;</span><span class="overlap"><span class="overlap_tag">&lt;1&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap_tag 1">&lt;/1&gt;</span></span> okay <span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S2&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_4"><span class="line_no">PRpan585:4</span><span class="sid " id="src_PRpan585_u_4_PRpan585_S2">S2: </span><span class="utext"><span class="to_tag">&lt;to S1&gt;</span><span class="smode">&lt;soft&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S1&gt;</span><span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_5"><span class="line_no">PRpan585:5</span><span class="sid " id="src_PRpan585_u_5_PRpan585_S1">S1: </span><span class="utext"><span class="to_tag">&lt;to S2&gt;</span><span class="smode">&lt;soft&gt;</span> we swap?<span class="pause"> (.) </span> okay <span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S2&gt;</span> e:r it is what we are talking about is a temporal lobe epilepsy <span class="pause"> (.) </span> which <span class="emph"> CON</span>sists of seizures <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> ordinating <span class="pvc_tag"> &lt;/pvc&gt; </span></span> from  (medial)  temporal structures <span class="pause"> (.) </span> associated with <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis so <span class="pause"> (.) </span> we are <span class="emph"> NOT </span> dealing with <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis it<span class="emph">SELF </span> (per se)  because i mean we know that there are patients with a <span class="pause"> (.) </span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> scan but <span class="emph"> NOT </span> seizures or there are <span class="pause"> (.) </span> patients who are <span class="pause"> (.) </span> minimal  controlled <span class="emph"> AL</span>though they have the same station. so we are talking about the refractory patients with <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis <span class="pause"> (.) </span><span class="emph"> AND </span> with temporal lobe epilepsy <span class="pause"> (4) </span> and <span class="emph"> THIS </span> just a definition you a:ll i know you all know it but <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> refer to the <span class="emph"> DY</span>namic process <span class="pause"> (.) </span> underlying the natural history <span class="pause"> (.) </span> of an epileptic disorders <span class="pause"> (.) </span> disorder <span class="pause"> (3) </span> and in the reproduction <span class="pause"> (.) </span> is the process <span class="pause"> (.) </span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> prevented.<span class="pause"> (2) </span> now i will <span class="pause"> (.) </span> er show you some animation <span class="vocal"> @@ </span> e:r just to <span class="pause"> (.) </span> explain the station <span class="pause"> (.) </span> what <span class="emph"> WE </span> need usually we need an initial <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>presʊər'teɪtɪŋ<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> injury to trigger the er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis <span class="vocal">&lt;clears throat&gt;</span><span class="pause"> (.) </span> so it is usually a prolonged <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> seizure hypoxia and <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> it can be infections which is very important because we have now <span class="pause"> (.) </span> a:n distinguished neuroscientist we will discuss about  this issue <span class="pause"> (.) </span> it can be again trauma <span class="emph"> AND </span> there are some patients which  we cannot find any er significant risk factor.<span class="pause"> (1) </span> there is identical backgrou:nd question mark <span class="pause"> (.) </span> there are studies showing some er familiar forms <span class="pause"> (2) </span> and the pre-existing  abnormality <span class="pause"> (.) </span> again there are a lot of studies showing that there is <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> heterotopia <span class="pvc_tag"> &lt;/pvc&gt; </span></span> quite good dysphasia b- as a du<span class="emph">AL </span> pathology within the hippocampus itself <span class="pause"> (3) </span> so:?<span class="pause"> (.) </span> there is a latent period <span class="pause"> (.) </span> sometimes people say it is a <span class="emph"> SILENT </span> period which is not really very <span class="emph"> SILENT </span><span class="pause"> (.) </span> because it is the <span class="pause"> (.) </span> period which hippocampu- er which of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> e:r take part <span class="pause"> (1) </span> and then we have the temporal lobe seizures.<span class="pause"> (1) </span> so just to show another <span class="pause"> (.) </span> one <span class="pause"> (.) </span><span class="to_tag">&lt;to SX&gt;</span><span class="smode">&lt;soft&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to SX&gt;</span> initial <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>presʊər'teɪtɪŋ<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> injury <span class="pause"> (.) </span><span class="emph"> THEN </span> cer:tain:<span class="pause"> (.) </span> lot of things er going on with normal laws <span class="pause"> (.) </span> it is the reorganization of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (neurostructures) <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> INCLUDING </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (neurolaws) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and lot of other things <span class="pause"> (1) </span> and the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and the epilepsy <span class="pause"> (.) </span> and we have the er er <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> proteins <span class="pause"> (.) </span> there are maybe some treatments <span class="emph"> SOON </span> after injury or <span class="pause"> (.) </span> during the injury <span class="pause"> (.) </span> there is the treatment during latent phase which we usually miss that phase <span class="pause"> (2) </span> and there is the refractory period which we we which we try <span class="emph"> ALL </span> kinds of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> untypic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs with unsecs- uncess- <span class="smode">&lt;slow&gt;</span> unsuccessful <span class="smode">&lt;/slow&gt;</span> results <span class="pause"> (.) </span> and we send usually patients to the surgery.<span class="pause"> (.) </span> so:<span class="pause"> (.) </span> maybe we need to identify the patients at risk at the very very <span class="pause"> (.) </span> e:r early period when <span class="emph"> THEY </span> have the first initial <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>presʊər'teɪtɪŋ<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> injury <span class="pause"> (1) </span> maybe a vaccine i don't know or maybe a gym therapy?<span class="pause"> (.) </span> or <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroprotective <span class="pvc_tag"> &lt;/pvc&gt; </span></span> strategies?<span class="pause"> (.) </span> or a disease modification?<span class="pause"> (1) </span> or maybe some kind of surgical restoration e:r <span class="pause"> (.) </span> techniques <span class="pause"> (.) </span> or some new tactics or <span class="emph"> TE</span>chniques for the surgery <span class="pause"> (.) </span> so during this discussion e:r session <span class="pause"> (.) </span> we will have er four distinguished neurosciences <span class="pause"> (.) </span> covering <span class="pause"> (.) </span><span class="emph"> DIFFERENT </span> issues different <span class="emph"> ASPECTS </span> interpret  of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pause"> (.) </span><span class="smode">&lt;soft&gt;</span> and <span class="smode">&lt;/soft&gt;</span> we will hear maybe we can find some clues <span class="pause"> (.) </span> er from their studies to prevent this <span class="pause"> (.) </span> serious  disabling disease.<span class="pause"> (2) </span> so a:h i want to invite first doctor  [S3]  [S3/last] ? we have a slight diff- er change in the program? she will be speaking first and then you can ask the questions after her speech <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_6"><span class="line_no">PRpan585:6</span><span class="sid " id="src_PRpan585_u_6_PRpan585_S3">S3: </span><span class="utext"> thank you very much to doctor  [S1/last] <span class="pause"> (.) </span> for inviting me <span class="pause"> (.) </span> here?<span class="pause"> (2) </span> and er <span class="vocal">&lt;clears throat&gt;</span><span class="pause"> (5) </span><span class="smode">&lt;soft&gt;</span> okay <span class="smode">&lt;/soft&gt;</span> hh so in my talk i will show you erm very briefly <span class="pause"> (.) </span> some evidence for the production and expression of inflammatory molecules <span class="pause"> (.) </span> in the brain during seizures in using experimental models.<span class="pause"> (.) </span> and er i will show you more extensively erm <span class="pause"> (.) </span> data er that er try to understand the function and meaning of this  production and if this  molecules have an impact <span class="pause"> (.) </span> on seizure activity.<span class="pause"> (1) </span> and er finally i would like er to highlight <span class="pause"> (.) </span> er er:m <span class="pause"> (.) </span> the possibility of er the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> er new pharmacological strategies <span class="pause"> (.) </span> by looking at e:r targets novel targets that er er can be envisag<span class="emph">ED </span> by er this  experimental <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> studies.<span class="pause"> (3) </span> this is a summary slide showing you <span class="pause"> (.) </span> er which are the data available in the literature?<span class="pause"> (.) </span> er that <span class="emph"> A</span>ssociate inflammation in brain with seizure activity.<span class="pause"> (1) </span><span class="vocal">&lt;smacks lips&gt;</span> and it has been shown that various <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> drugs <span class="pause"> (.) </span> replied in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> in uses <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> synthesis in various for brain areas involving initiation and propagation of seizures.<span class="pause"> (.) </span> it has been shown that transgenic mice <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpressing <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>lɪə<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> but not in neurons? sho:w enhanced seizure susceptibility and there is also evidence for <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neurodegeneration <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in this  animals <span class="pause"> (.) </span> and there are relatively old pharmacologically tha- showing that er er some <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-flammatory <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs <span class="pause"> (.) </span> er can have anti-<span class="unintelligible"><span class="un_tag">&lt;un&gt;</span>xxx <span class="un_tag">&lt;/un&gt;</span></span> properties in experimental models <span class="pause"> (2) </span> what about the human brain. there is evidence for enhanced <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroactivity <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>lɪə<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> in temporal epilepsy sufferers? and it is well known that there is a functional activation of both micro- <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> industrosites <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in temporal lobe epilepsy  (issue)  and this  are the cells that produces <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> the main sources of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> production in brain. hh er and it's got to be a <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (transcriptional) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> factor which is the crucial involving inflammatory reaction has been shown to be <span class="pause"> (.) </span><span class="emph"> ENHANCED </span><span class="pause"> (.) </span> in a tissue from  (amnesia amnesia)  temporal lobe epilepsy and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis hh there is also evidence for er activation of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> network in patients with after recent experience of generalized <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> seizures hh and er er <span class="vocal">&lt;clears throat&gt;</span> there is also recent evidence for a function of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> polymorphisma <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> beta gene <span class="pause"> (.) </span> er which is er er apparently associated with enhanced  (stability)  of this individual <span class="pause"> (.) </span> to produce <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> after <span class="pause"> (.) </span> er a proper stimulus? and this <span class="pause"> (.) </span> functional <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> polymorphism <span class="pvc_tag"> &lt;/pvc&gt; </span></span> has been found in temporal lobe epilepsy <span class="emph"> WITH </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis and in children <span class="pause"> (.) </span> children with prolonged fibre seizures.<span class="pause"> (2) </span> hh so the evidence that have been collected in the literature show that the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> are synthesizing the brain mostly past by resident er <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>lɪə<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> hh er after the synthesis they can be released and act on the other set  also that are located both on <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>lɪə<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="un_tag">&lt;/un&gt;</span></span> and the neurons?<span class="pause"> (.) </span> a:nd thereafter the trigger the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> transcellular <span class="pvc_tag"> &lt;/pvc&gt; </span></span> (signalling)  cascade that may lead to rapid changes in the ionic currents? hh or to more er:m <span class="pause"> (.) </span> time-consuming i would <span class="smode">&lt;@&gt;</span> say <span class="smode">&lt;/@&gt;</span> er changes that require gene transcription <span class="pause"> (2) </span> i will focus my presentation on the role of two <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> (inflammatory) <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in seizures?<span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (ionone) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> beta and <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> and this are the people who contributed to this  studies in my life <span class="pause"> (1) </span> er: so our first approach was that of evaluating if <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (ionone) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> beta was?<span class="pause"> (.) </span> produced?<span class="pause"> (.) </span> in epileptic tissue?<span class="pause"> (.) </span> in r- rats by applying er electrical stimulation of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> hippocampus with a  (vertebral)  stimulation that is in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> use an acute status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> that last and is <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> self-sustaining <span class="pvc_tag"> &lt;/pvc&gt; </span></span> it er it it is occurring also after the end of the sixty minute stimulation and is a self-s- -sustaining status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> that can be monitored <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> electrocorticographically <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> last for about eighteen twenty-four hours <span class="pause"> (.) </span> then the animal went to a: so-called latency period with no apparent <span class="pause"> (.) </span><span class="vocal">&lt;swallows&gt;</span> abnormalities in  <span class="spel_tag">&lt;spel&gt;</span> e e g  <span class="spel_tag">&lt;/spel&gt;</span> er and in the behavior <span class="pause"> (.) </span> and then they develop er spontaneous recurrent seizures </span></div>
         
         
         <div class="gap">(gap 00:12:48) <span>{mon; S3 continues talking about the experiment and its results}</span></div>
         
         
         <div class="u " id="PRpan585_u_7"><span class="line_no">PRpan585:7</span><span class="sid " id="src_PRpan585_u_7_PRpan585_S3">S3: </span><span class="utext"><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> in in the brain by resident <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> and has <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> effects <span class="pause"> (.) </span> that its <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> receptorant <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> agonist <span class="pvc_tag"> &lt;/pvc&gt; </span></span> mediates powerful anti-<span class="unintelligible"><span class="un_tag">&lt;un&gt;</span>xxx <span class="un_tag">&lt;/un&gt;</span></span> actions <span class="pause"> (.) </span> and we can afford in experimental models significant inhibition of seizures by blocking <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (ionone) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> beta <span class="pause"> (.) </span> actions <span class="pause"> (2) </span> very briefly?<span class="pause"> (.) </span> to finish hh we have also explored a little bit <span class="to_tag">&lt;to S1&gt;</span> how much time we have?<span class="to_tag">&lt;/to S1&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_8"><span class="line_no">PRpan585:8</span><span class="sid " id="src_PRpan585_u_8_PRpan585_S1">S1: </span><span class="utext"><span class="to_tag">&lt;to S3&gt;</span><span class="smode">&lt;soft&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S3&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_9"><span class="line_no">PRpan585:9</span><span class="sid " id="src_PRpan585_u_9_PRpan585_S3">S3: </span><span class="utext"><span class="to_tag">&lt;to S1&gt;</span> two minutes?<span class="to_tag">&lt;/to S1&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_10"><span class="line_no">PRpan585:10</span><span class="sid " id="src_PRpan585_u_10_PRpan585_S1">S1: </span><span class="utext"><span class="to_tag">&lt;to S3&gt;</span><span class="smode">&lt;soft&gt;</span> two minutes <span class="smode">&lt;/soft&gt;</span><span class="to_tag">&lt;/to S3&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_11"><span class="line_no">PRpan585:11</span><span class="sid " id="src_PRpan585_u_11_PRpan585_S3">S3: </span><span class="utext"><span class="to_tag">&lt;to S1&gt;</span> mhm <span class="to_tag">&lt;/to S1&gt;</span> we have also explored the er: effect of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five)  that is another <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> it is produce a significant amount during epileptic activity.<span class="pause"> (.) </span> and this produced <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (1) </span> and er we did this as a functional experiment in <span class="emph"> MICE </span>? where a <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> was <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampally <span class="pvc_tag"> &lt;/pvc&gt; </span></span> applied <span class="pause"> (.) </span> and again also in this model there is?<span class="pause"> (.) </span> in both strains of mice we have used a production of er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neo-synthesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> in in the hippocampus.<span class="pause"> (1) </span> when we applied <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five) <span class="pause"> (.) </span> to the mouse brain before application of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> we quite unexpectedly found a  (protect) <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (evactions) <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> so the:<span class="pause"> (.) </span> number of seizures and the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> activity were significantly reduced in a dose that final manner by the application of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five) .<span class="pause"> (1) </span> if we used mice that <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpressed <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five)  in <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> astrocytes <span class="pvc_tag"> &lt;/pvc&gt; </span></span> they are less susceptible to seizure activity <span class="pause"> (.) </span> as you can see <span class="emph"> HERE </span> they are for <span class="emph"> SUPPORTING </span><span class="pause"> (.) </span> an <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> inhibitory <span class="pvc_tag"> &lt;/pvc&gt; </span></span> role of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five)  produced <span class="pause"> (.) </span> in the brain <span class="pause"> (.) </span> on seizure activity.<span class="pause"> (.) </span> and it is known that the effect of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five)  cannot  (cause two)  two different receptor <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> subtypes <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and one receptor <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> subtype <span class="pvc_tag"> &lt;/pvc&gt; </span></span> is called  <span class="spel_tag">&lt;spel&gt;</span> b  <span class="spel_tag">&lt;/spel&gt;</span> seventy-five <span class="pause"> (.) </span> appears to be involved in <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroprotective <span class="pvc_tag"> &lt;/pvc&gt; </span></span> effects of this <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> and using knock out mice lacking the  <span class="spel_tag">&lt;spel&gt;</span> b  <span class="spel_tag">&lt;/spel&gt;</span> seventy-five receptors we found out that they have more seizures <span class="pause"> (.) </span> therefore supporting that <span class="emph"> THIS </span> receptor <span class="pause"> (.) </span> may be responsible for the er anti- <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> effects of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> hh when we test animals lacking the  <span class="spel_tag">&lt;spel&gt;</span> b  <span class="spel_tag">&lt;/spel&gt;</span> fifty-five receptors we find the less  seizures <span class="pause"> (.) </span> and this may mean that there is an  (extra) <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> component of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> going through the  <span class="spel_tag">&lt;spel&gt;</span> b  <span class="spel_tag">&lt;/spel&gt;</span> fifty-five receptors hh so again <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five)  er <span class="emph"> MIGHT </span> have <span class="pause"> (.) </span> a double effect although we know that when we apply <span class="pause"> (.) </span> or when we <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpressed <span class="pvc_tag"> &lt;/pvc&gt; </span></span> the predominant effect is <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> inhibitory.<span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (3) </span> so <span class="pause"> (.) </span> what about the possible <span class="pause"> (.) </span> therapeutic implications of this later of course this  are <span class="pause"> (.) </span> still very preliminary <span class="pause"> (.) </span> er although sound er er  (product) <span class="pause"> (.) </span> a classical <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neurotransmission <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> this  are novel molecules compared to classical anti- <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> drugs with er er <span class="pause"> (.) </span> very different mechanism  of actions?<span class="pause"> (.) </span> so there there <span class="emph"> MIGHT </span> be the hope of er er evading those mechanism  be of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistance <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of tolerance hh that er we kno:w are part of the er problems linked to the current medical therapy.<span class="pause"> (.) </span> there are drugs already available <span class="pause"> (.) </span> particularly from er for inflammatory <span class="pause"> (.) </span> er diseases er or autoimmune diseases that are <span class="pause"> (.) </span> very well tolerated in humans and of course there is the problem of making this drug passing the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxx <span class="un_tag">&lt;/un&gt;</span></span> since they are not very permeable? hh and i didn't have time <span class="emph"> HERE </span> but there is also erm <span class="pause"> (.) </span> evidence that <span class="pause"> (1) </span> er for inflammatory  in molecules and this <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytokines <span class="pvc_tag"> &lt;/pvc&gt; </span></span> have a role in seizure associated <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neurono <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cell loss <span class="pause"> (.) </span> and therefore they ma:y also be responsible for damage associated seizures and play role <span class="pause"> (.) </span> in the progression of the disease <span class="pause"> (.) </span> thank you very much </span></div>
         
         <div class="u " id="PRpan585_u_12"><span class="line_no">PRpan585:12</span><span class="sid " id="src_PRpan585_u_12_PRpan585_SS">SS: </span><span class="utext"><span class="vocal">&lt;applauds&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_13"><span class="line_no">PRpan585:13</span><span class="sid " id="src_PRpan585_u_13_PRpan585_S1">S1: </span><span class="utext"> thank you very much doctor  [S3/last]  for this extensive information on inflammation and <span class="pause"> (.) </span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> and  (estimations)  is there any <span class="pause"> (.) </span> comments or: questions er to doctor  [S3/last]  she has to leave us so </span></div>
         
         <div class="u " id="PRpan585_u_14"><span class="line_no">PRpan585:14</span><span class="sid " id="src_PRpan585_u_14_PRpan585_SX-f">SX-f: </span><span class="utext"><span class="smode">&lt;soft&gt;</span><span class="vocal"> @@ </span><span class="smode">&lt;/soft&gt;</span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_15"><span class="line_no">PRpan585:15</span><span class="sid " id="src_PRpan585_u_15_PRpan585_S1">S1: </span><span class="utext"> er <span class="pause"> (.) </span> you have to ask the questions now <span class="pause"> (3) </span> no comments? doctor <span class="pause"> (.) </span> yah please </span></div>
         
         <div class="u " id="PRpan585_u_16"><span class="line_no">PRpan585:16</span><span class="sid " id="src_PRpan585_u_16_PRpan585_S4">S4: </span><span class="utext"> er am i er <span class="pause"> (.) </span> maybe i <span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> missed something but <span class="overlap_tag 2">&lt;/2&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_17"><span class="line_no">PRpan585:17</span><span class="sid " id="src_PRpan585_u_17_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> would you please sit <span class="overlap_tag 2">&lt;/2&gt;</span></span> down and  </span></div>
         
         <div class="u " id="PRpan585_u_18"><span class="line_no">PRpan585:18</span><span class="sid " id="src_PRpan585_u_18_PRpan585_S4">S4: </span><span class="utext"> sorry  </span></div>
         
         <div class="u " id="PRpan585_u_19"><span class="line_no">PRpan585:19</span><span class="sid " id="src_PRpan585_u_19_PRpan585_S1">S1: </span><span class="utext"> er stand <span class="overlap"><span class="overlap_tag">&lt;3&gt;</span><span class="smode">&lt;@&gt;</span> up <span class="smode">&lt;/@&gt;</span> stand up <span class="overlap_tag 3">&lt;/3&gt;</span></span><span class="pause"> (1) </span></span></div>
         
         <div class="u " id="PRpan585_u_20"><span class="line_no">PRpan585:20</span><span class="sid " id="src_PRpan585_u_20_PRpan585_SS">SS: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;3&gt;</span><span class="vocal"> @@ </span><span class="overlap_tag 3">&lt;/3&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_21"><span class="line_no">PRpan585:21</span><span class="sid " id="src_PRpan585_u_21_PRpan585_S4">S4: </span><span class="utext"> maybe i missed something but w- when you talked about the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> model in the: in the mice <span class="pause"> (.) </span> what did you <span class="emph"> MEASURE </span><span class="pause"> (.) </span><span class="emph"> EXACTLY </span> did you measure the <span class="pause"> (.) </span> seizures to the status? or did you measure <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> seizures <span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> in the different <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap_tag 4">&lt;/4&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_22"><span class="line_no">PRpan585:22</span><span class="sid " id="src_PRpan585_u_22_PRpan585_S3">S3: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> we applied <span class="overlap_tag 4">&lt;/4&gt;</span></span> a very low <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> dosis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> in mice not in using status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> but er e:r repetitive short <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> electrocorticographic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> seizures <span class="pause"> (.) </span> and this  were the seizures that we found to be <span class="pause"> (.) </span> modulated by <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (five) <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_23"><span class="line_no">PRpan585:23</span><span class="sid " id="src_PRpan585_u_23_PRpan585_S4">S4: </span><span class="utext"> but <span class="pause"> (.) </span> these were measured immediately after they came into injection </span></div>
         
         <div class="u " id="PRpan585_u_24"><span class="line_no">PRpan585:24</span><span class="sid " id="src_PRpan585_u_24_PRpan585_S3">S3: </span><span class="utext"> in the la- in the next three <span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> hours <span class="overlap_tag 5">&lt;/5&gt;</span></span> after the injection <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_25"><span class="line_no">PRpan585:25</span><span class="sid " id="src_PRpan585_u_25_PRpan585_S4">S4: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> ah okay <span class="overlap_tag 5">&lt;/5&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_26"><span class="line_no">PRpan585:26</span><span class="sid " id="src_PRpan585_u_26_PRpan585_S3">S3: </span><span class="utext"> they last for three hours and then er <span class="pause"> (.) </span><span class="smode">&lt;soft&gt;</span> they expired <span class="smode">&lt;/soft&gt;</span><span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_27"><span class="line_no">PRpan585:27</span><span class="sid " id="src_PRpan585_u_27_PRpan585_S1">S1: </span><span class="utext"> any more questions?<span class="pause"> (1) </span> we  (have one)  study published in epilepsia a year ago and we showed that in a certain <span class="pause"> (.) </span> group of patient with <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampasic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis <span class="pause"> (.) </span> are er are showed <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxxxx <span class="un_tag">&lt;/un&gt;</span></span> class <span class="emph"> TWO </span>.<span class="pause"> (.) </span> er antigens.<span class="pause"> (.) </span> so i don't know if:<span class="pause"> (.) </span> there are maybe some er relevance with your findings with the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> system and so on <span class="pause"> (.) </span> but apparently there is really <span class="pause"> (.) </span> some sort of important er aspect er of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> system and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> so maybe we can <span class="pause"> (.) </span><span class="emph"> USE </span><span class="pause"> (.) </span> as you said as you recommend us some anti-inflammatory agents <span class="pause"> (.) </span> right after the <span class="pause"> (.) </span> maybe severe  (encephalitis) <span class="pause"> (.) </span> but <span class="pause"> (.) </span> of course we need to identify those patients.<span class="pause"> (.) </span> but we use anyhow some anti-inflammatory <span class="pause"> (.) </span> usually <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (anti-practic) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> agents <span class="pause"> (.) </span> so maybe if we can <span class="pause"> (.) </span> kind of <span class="emph"> E</span>laborate the sort of <span class="pause"> (.) </span> agents that <span class="pause"> (.) </span><span class="emph"> ALL </span> set the same time <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (anti-practic) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and anti-inflammatory and also can cause bl-  (blood-building barrier?) hh so maybe we can protect <span class="pause"> (.) </span> some <span class="pause"> (.) </span> mhm some group of patients at least <span class="pause"> (.) </span> e:r from <span class="pause"> (.) </span> the:<span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenetic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> process <span class="pause"> (.) </span> so you have any?<span class="pause"> (.) </span> anybody has any opinion on this?<span class="pause"> (.) </span> are there any cognitions around us and <span class="pause"> (.) </span> make some <span class="pause"> (.) </span><span class="emph"> MORE </span> comments? as a cognition we need <span class="pause"> (.) </span> more concrete you know <span class="pause"> (.) </span> solutions so <span class="pause"> (.) </span> you summarized it that that we we may have some <span class="emph"> HOPE </span> from <span class="pause"> (.) </span> this  studies <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_28"><span class="line_no">PRpan585:28</span><span class="sid " id="src_PRpan585_u_28_PRpan585_S3">S3: </span><span class="utext"><span class="other_continuation"> = </span> well i think that er of <span class="pause"> (.) </span> this data show that in the experimental models there is a component of inflammation that can be <span class="pause"> (.) </span> targeted <span class="pause"> (.) </span> to inhibit seizures so it might <span class="pause"> (.) </span> not be <span class="pause"> (.) </span><span class="emph"> ENOUGH </span> but in a- addition to other treatments may have <span class="pause"> (.) </span> and maybe <span class="pause"> (.) </span> could be helpful al- also for those kind  of seizure that are not er <span class="pause"> (.) </span> susceptible to current therapy of course this is just an  hypothesis because it has to be tested at <span class="overlap"><span class="overlap_tag">&lt;6&gt;</span> first <span class="overlap_tag 6">&lt;/6&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_29"><span class="line_no">PRpan585:29</span><span class="sid " id="src_PRpan585_u_29_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;6&gt;</span> mhm <span class="overlap_tag 6">&lt;/6&gt;</span></span> mhm <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_30"><span class="line_no">PRpan585:30</span><span class="sid " id="src_PRpan585_u_30_PRpan585_S3">S3: </span><span class="utext"><span class="other_continuation"> = </span> but there is a significant impact on seizure activity when you interfere with the production of this molecules  and also
               on <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neurono <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cell loss so i think that is <span class="pause"> (.) </span> an important system to be taken into to consideration for <span class="pause"> (.) </span> possible novel <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> developments <span class="pause"> (1) </span></span></div>
         
         <div class="u " id="PRpan585_u_31"><span class="line_no">PRpan585:31</span><span class="sid " id="src_PRpan585_u_31_PRpan585_S1">S1: </span><span class="utext"> okay thank you very much er: i think that nobody will ask any more questions thank you <span class="pause"> (.) </span> now we will move to the second er: speaker doctor  [S5/last]  [S5/last] <span class="pause"> (.) </span> this morning you heard about er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> resistance a lot but you will hear it now from a different aspect in terms of <span class="pause"> (.) </span> er protection or prevention of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (3) </span></span></div>
         
         <div class="u " id="PRpan585_u_32"><span class="line_no">PRpan585:32</span><span class="sid " id="src_PRpan585_u_32_PRpan585_S5">S5: </span><span class="utext"> so <span class="pause"> (.) </span> thank you for inviting me and <span class="pause"> (.) </span> pr- i was ask to talk about <span class="pause"> (.) </span> the possibility of overcoming <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pause"> (.) </span> first of all i wish to apologize because i will use some of the slides which i used in the <span class="pause"> (.) </span> main session this morning <span class="pause"> (.) </span> on remission versus <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> refractoriness <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> erm <span class="pause"> (.) </span> so first of all <span class="pause"> (1) </span><span class="vocal">&lt;smacks lips&gt;</span> erm it's important to consider that <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and temporal epilepsy of course is one of the major problems in <span class="pause"> (.) </span> the treatment of this type of epilepsy <span class="pause"> (.) </span> because patients with <span class="pause"> (.) </span> from resistant temporal lobe epilepsy and other types of epilepsy of course <span class="pause"> (.) </span> have an increase in <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> psychosocial <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and physical immobility <span class="pause"> (.) </span> and so mortality is greatly increased <span class="pause"> (.) </span> erm <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> that of the general population.<span class="pause"> (.) </span> unfortunately only a small number of these  (infected)  patients <span class="pause"> (.) </span> can be successfully treated by surgical <span class="pause"> (.) </span> treatment of epilepsy and therefore we <span class="emph"> NEED </span><span class="pause"> (.) </span> novel therapeutic approaches <span class="pause"> (.) </span> erm for <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> temporal lobe epilepsy and of course also other types <span class="pause"> (.) </span> of epilepsy <span class="pause"> (.) </span> so we heard in the main <span class="emph"> SESSION </span> on <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> refractoriness <span class="pvc_tag"> &lt;/pvc&gt; </span></span> this morning that there are <span class="pause"> (.) </span> different scenarios for <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> and er i showed part of the slide this morning <span class="pause"> (.) </span> erm so <span class="pause"> (.) </span> there are at least <span class="emph"> TWO </span> one is that patients are <span class="pause"> (.) </span> predetermined to become refractory at the time of their first seizure and <span class="pause"> (.) </span> probably the only explanation for that <span class="pause"> (.) </span> is that there must be <span class="pause"> (.) </span> erm a a <span class="pause"> (.) </span> certain <span class="pause"> (.) </span> genome in these patients explaining why they do not respond <span class="pause"> (.) </span> to treatment whereas other patients with <span class="pause"> (.) </span> -th apparently  at least the same type <span class="pause"> (.) </span> of epilepsy <span class="emph"> DO </span> respond <span class="pause"> (.) </span> so the only explanation for that on my mind <span class="pause"> (.) </span> is genome di- <span class="pause"> (.) </span> diversity <span class="pause"> (.) </span> but there is a second population of patients <span class="pause"> (.) </span> erm who initially respond to treatment <span class="pause"> (.) </span> but then they progress to a refractory state of a time and this can take take several years <span class="pause"> (.) </span> erm and <span class="pause"> (.) </span> there are several explanations for that but one very naive explanation is that <span class="pause"> (.) </span> the disease progressive progress er shows progression under the treatment <span class="pause"> (.) </span> so most likely both scenarios exist and there are certainly <span class="pause"> (.) </span> many other scenarios <span class="pause"> (.) </span> hh erm if <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> refractoriness <span class="pvc_tag"> &lt;/pvc&gt; </span></span> is <span class="emph"> NOT </span> predetermined in a given patient <span class="pause"> (.) </span> it might be prevented by aggressive therapy at an early stage? as has been proposed by  [first name1]  [last name1] <span class="pause"> (.) </span> two years ago in a review on that <span class="pause"> (.) </span> ideally <span class="pause"> (.) </span> for that purpose <span class="pause"> (.) </span> we would need <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs with a disease-<span class="emph">MODIFYING </span> effect <span class="pause"> (.) </span> however <span class="pause"> (.) </span> at least to <span class="emph"> MY </span> knowledge we do not yet <span class="emph"> HAVE </span> such <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs which are really <span class="pause"> (.) </span> disease-modifying <span class="pause"> (.) </span> so once again in general <span class="pause"> (.) </span> there is a need to develop new strategies <span class="pause"> (.) </span> that prevent or reverse the mechanisms <span class="pause"> (.) </span> underlying <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span><span class="vocal">&lt;smacks lips&gt;</span> hh and the problem which we <span class="emph"> HAVE </span> here <span class="pause"> (.) </span> er but several groups are working on that over the last ten years or so <span class="pause"> (.) </span> is that mechanisms of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> are poorly understood <span class="pause"> (.) </span> but <span class="pause"> (.) </span> erm if you compare what we <span class="pause"> (.) </span> knew about this ten years ago there had been a tremendous increase in knowledge <span class="pause"> (.) </span> and part of that will be <span class="pause"> (.) </span> er  (referred to)  in my talk <span class="pause"> (.) </span> so <span class="pause"> (.) </span> several groups use <span class="pause"> (.) </span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> from <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> patients to study <span class="pause"> (.) </span> erm mechanisms of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and i will give you a few examples in a moment <span class="pause"> (.) </span> erm different groups including  [first name6]  [last name6]'s group from the <span class="pause"> (.) </span> (university)  college in  [place1] <span class="pause"> (.) </span> erm are using genome profiling of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> patients and compare them <span class="pause"> (.) </span> erm <span class="vocal">&lt;smacks lips&gt;</span> this genome profiling this <span class="pause"> (.) </span> pharmacological <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> there are some in vitro models and the increase in number of animal <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> epilepsy this which can be used <span class="pause"> (.) </span> erm to study mechanisms.<span class="pause"> (1) </span> erm <span class="pause"> (.) </span> another slide which i showed this morning just to remember <span class="pause"> (.) </span> or to remind you <span class="pause"> (.) </span> erm that there are diverse possibilities <span class="emph"> APART </span> from the two which i will concentrate upon <span class="pause"> (.) </span> er such as genetics <span class="pause"> (.) </span> such as <span class="pause"> (.) </span> different disease related mechanisms <span class="pause"> (.) </span> including the ideology of the seizures <span class="pause"> (.) </span> the already mentioned progression <span class="pause"> (.) </span> of epilepsy <span class="pause"> (.) </span> but i will concentrate on two <span class="pause"> (.) </span> which is a drug target hypothesis of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> erm epilepsy and the <span class="pause"> (.) </span> brain drug uptake hypothesis <span class="pause"> (1) </span> so <span class="pause"> (.) </span> these will be the two topics of my talk and i will start <span class="pause"> (.) </span> by <span class="emph"> RE</span>viewing studies on  (changes in)  drug target <span class="pause"> (.) </span> targets both in erm <span class="pause"> (.) </span> patients with  (intractable)  epilepsy and an <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> of temporal  (lobe)  epilepsy <span class="pause"> (.) </span> and then proceed to <span class="emph"> RE</span>view  er studies on  (changes in)  brain uptake of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs <span class="pause"> (.) </span> so to start with  (the already mentioned)  drug <span class="emph"> TARGETS </span> the so-called drug target hypothesis of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> epilepsy <span class="pause"> (.) </span> erm the basis of this hypothesis is that several major <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs including <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenytoin <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> carbamazapine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> lamotrigine <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> act <span class="pause"> (.) </span> via modulation of voltage-activated <span class="emph"> SODIUM </span> channels </span></div>
         
         
         <div class="gap">(gap 00:16:16) <span>{mon; S5 continues reviewing previous studies}</span></div>
         
         
         <div class="u " id="PRpan585_u_33"><span class="line_no">PRpan585:33</span><span class="sid " id="src_PRpan585_u_33_PRpan585_S5">S5: </span><span class="utext"> again two subgroups <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> this is <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pre-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> seizure frequency <span class="pause"> (.) </span> so these animals had about twelve seizures over a period of two weeks?<span class="pause"> (.) </span> this was <span class="pause"> (.) </span> suppressed to almost zero <span class="pause"> (.) </span> growing two weeks of treatment <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx?<span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> and then after the treatment <span class="pause"> (.) </span> er seizure frequency was again <span class="emph"> IN</span>creased <span class="pause"> (.) </span> so we turned these animals <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and the second group four animals of these eleven <span class="pause"> (.) </span> that turned <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> because there was no drug effect at all <span class="pause"> (.) </span> again the plasma concentrations were the same in these two subgroups <span class="pause"> (.) </span> and then we looked on <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> protein expression in these two <span class="pause"> (.) </span> extreme groups <span class="pause"> (1) </span> and found this data <span class="pause"> (.) </span> which is a <span class="emph"> VERY </span> marked <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> protein and the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> compared to the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in several brain regions such as the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> prefront <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cortex <span class="pause"> (.) </span> the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> and the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> one layer of the hippocampus <span class="pause"> (1) </span> so <span class="pause"> (1) </span> of course the next question then and this goes back to the title of my talk <span class="pause"> (1) </span> is <span class="pause"> (1) </span> taken <span class="pause"> (.) </span> all this data <span class="pause"> (.) </span> or <span class="pause"> (.) </span> in view of all this data indicating <span class="pause"> (.) </span> that <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters might be respondibl- responsible at least on part for <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> in intractable epilepsy that might be possible <span class="pause"> (.) </span> to reverse or prevent <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> epilepsy by <span class="pause"> (.) </span> inhibition <span class="pause"> (.) </span> of these <span class="emph"> TRANS</span>porters <span class="pause"> (1) </span> and i alr- ready mentioned that in the morning session that <span class="pause"> (.) </span> various of these <span class="pause"> (.) </span> er inhibitors of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> protein and more recently also inhibitors of  <span class="spel_tag">&lt;spel&gt;</span> m r ps  <span class="spel_tag">&lt;/spel&gt;</span><span class="pause"> (.) </span> are currently in the clinic?<span class="pause"> (.) </span> and are evaluated for reversal or prevention of <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> resistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in human <span class="emph"> CANCER </span><span class="pause"> (1) </span> erm so they are not toxic so are tolerated by: by patients and <span class="pause"> (.) </span> so they could be used <span class="pause"> (.) </span> erm for trials and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> epilepsy <span class="pause"> (.) </span> and <span class="pause"> (.) </span> we started to <span class="pause"> (.) </span> er carry out <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> studies <span class="pause"> (.) </span> er showing that <span class="pause"> (.) </span><span class="spel_tag">&lt;spel&gt;</span> p g p  <span class="spel_tag">&lt;/spel&gt;</span> or  <span class="spel_tag">&lt;spel&gt;</span> m r p  <span class="spel_tag">&lt;/spel&gt;</span> inhibition indeed results in enhanced <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxx <span class="un_tag">&lt;/un&gt;</span></span> efficacy of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs so <span class="pause"> (.) </span> this could form a novel strategy for overcoming <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> and <span class="pause"> (.) </span> once again the <span class="emph"> ADVANTAGE </span> here <span class="pause"> (.) </span> is that various of these inhibitors of  <span class="spel_tag">&lt;spel&gt;</span> p g p  <span class="spel_tag">&lt;/spel&gt;</span> and <span class="pause"> (.) </span> er  <span class="spel_tag">&lt;spel&gt;</span> m r ps  <span class="spel_tag">&lt;/spel&gt;</span><span class="emph"> ARE </span> clinically available we now speak of three generations <span class="pause"> (.) </span> of  <span class="spel_tag">&lt;spel&gt;</span> p g p  <span class="spel_tag">&lt;/spel&gt;</span> inhibitors <span class="pause"> (.) </span> and the third generation is the most interesting one because these compounds are very selective <span class="pause"> (.) </span> they are not toxic in humans and they show no effects <span class="pause"> (.) </span> on drug metabolism and several of these compounds <span class="pause"> (.) </span> erm <span class="pause"> (.) </span> shown here <span class="pause"> (.) </span> are in clinical phase two or three <span class="pause"> (.) </span> in cancer patients.<span class="pause"> (.) </span> and just to give you <span class="emph"> ONE </span> example at the end of my talk <span class="pause"> (.) </span> erm <span class="pause"> (.) </span> here we <span class="pause"> (.) </span> combined <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenitamine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> at a <span class="emph"> VERY </span> low <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> subeffective <span class="pvc_tag"> &lt;/pvc&gt; </span></span> dose <span class="pause"> (.) </span> is an inhibitor of  <span class="spel_tag">&lt;spel&gt;</span> m r p  <span class="spel_tag">&lt;/spel&gt;</span> one and  <span class="spel_tag">&lt;spel&gt;</span> m r p  <span class="spel_tag">&lt;/spel&gt;</span> two <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> probenecid <span class="pvc_tag"> &lt;/pvc&gt; </span></span> which is clinically available <span class="pause"> (.) </span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenitamine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> alone at this low dose on ra:ts? was doing nothing on the focused seizure so i show this is  (per cent above)  control <span class="pause"> (.) </span> control is set to zero <span class="pause"> (.) </span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> probenecid <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> ALONE </span> was doing nothing <span class="pause"> (.) </span> but when we combined the two there was this marked <span class="pause"> (.) </span> anti-<span class="unintelligible"><span class="un_tag">&lt;un&gt;</span>xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="emph"> E</span>ffect and this was associated <span class="pause"> (.) </span> with a marked increase of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenytoin <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenytoin's <span class="pvc_tag"> &lt;/pvc&gt; </span></span> concentration in the brain <span class="pause"> (.) </span> now what are we <span class="emph"> CURRENTLY </span> doing <span class="pause"> (.) </span> we currently use gene expression analysis by genome raise <span class="pause"> (.) </span> in <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> from the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> model to identify genes that are involved in drug <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> resistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and this study has just been completed <span class="pause"> (.) </span> and we found some sixty <span class="pause"> (.) </span> genes <span class="pause"> (.) </span> we screened for more than twenty <span class="emph"> THOUSAND </span> genes <span class="pause"> (.) </span> some <span class="emph"> SIXTY </span> of these twenty thousand <span class="pause"> (.) </span> erm which were differently <span class="pause"> (.) </span> red- reg- regulated being <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and we are on the way <span class="pause"> (.) </span> to identify this genes <span class="pause"> (.) </span> furthermore we currently study with a <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> polymorphisms <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporter genes are involved <span class="pause"> (.) </span> and drug <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> resistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in this <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> model of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phenytoin <span class="pvc_tag"> &lt;/pvc&gt; </span></span> resistant er temporal lobe epilepsy and this was initiated <span class="pause"> (.) </span> by a publication of some  [first name6]  [last name6]'s group last year in the new- in the journal of medicine <span class="pause"> (.) </span> in which they <span class="pause"> (.) </span> reported an association of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> resistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in epilepsy with <span class="emph"> A </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> polymorphism <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> in the drug transporter gene and coding for <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> protein.<span class="pause"> (1) </span> now to conclude <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters and their genes <span class="pause"> (.) </span> is a  novel and reasonable hypothesis to explain <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> resistance in epilepsy <span class="pause"> (.) </span> but of course further studies are needed <span class="pause"> (.) </span> to establish this concept <span class="pause"> (.) </span> and there is still a lack of <span class="emph"> A </span><span class="emph"> REAL </span> true proof of principle <span class="pause"> (.) </span> there are certainly other mechanisms of drug resistance that <span class="emph"> NEED </span> to be identified or substantiated such as <span class="pause"> (.) </span> disease related changes in drug <span class="emph"> TARGETS </span><span class="pause"> (.) </span> and finally <span class="pause"> (.) </span><span class="emph"> I </span> hope and we all <span class="pause"> (.) </span> all of those hopes who who are working on this <span class="pause"> (.) </span> hope that finally we will be able <span class="pause"> (.) </span> to er:m <span class="pause"> (.) </span> develop new strategies based on such er theories <span class="pause"> (.) </span> for reversal or prevention of <span class="pause"> (.) </span> er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> resistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in human epilepsy thank you </span></div>
         
         <div class="u " id="PRpan585_u_34"><span class="line_no">PRpan585:34</span><span class="sid " id="src_PRpan585_u_34_PRpan585_SS">SS: </span><span class="utext"><span class="vocal">&lt;applauds&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_35"><span class="line_no">PRpan585:35</span><span class="sid " id="src_PRpan585_u_35_PRpan585_S1">S1: </span><span class="utext"> thank you very much for this presentation <span class="pause"> (.) </span> er: any questions or remarks er for this presentation <span class="pause"> (2) </span> apparently we will have some <span class="emph"> HOPE </span>? to overcome er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistance <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> i may just quick question er if we? let's say start to give some <span class="pause"> (.) </span> if you if you brew <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (imbrew) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> the drug and be given to the other patients <span class="pause"> (.) </span> will it be after when they:'re er already <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant?<span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> hm <span class="pause"> (.) </span> so <span class="pause"> (.) </span> erm do we have to wait until they are they became <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant?<span class="pvc_tag"> &lt;/pvc&gt; </span></span> to a: certain to the drugs? or <span class="pause"> (.) </span> is it possible is there a possibility to: give it befor:e <span class="pause"> (.) </span> during that period <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_36"><span class="line_no">PRpan585:36</span><span class="sid " id="src_PRpan585_u_36_PRpan585_S5">S5: </span><span class="utext"> probably i didn't understand your question correctly but but is your question that it it's foreseeable <span class="pause"> (.) </span> whether a <span class="pause"> (.) </span> patient will be a <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responder <span class="pvc_tag"> &lt;/pvc&gt; </span></span> or <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responder <span class="pvc_tag"> &lt;/pvc&gt; </span></span> was that your question?<span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_37"><span class="line_no">PRpan585:37</span><span class="sid " id="src_PRpan585_u_37_PRpan585_S1">S1: </span><span class="utext"> yeah but i <span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> mean <span class="overlap_tag 7">&lt;/7&gt;</span></span> the main question maybe here <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_38"><span class="line_no">PRpan585:38</span><span class="sid " id="src_PRpan585_u_38_PRpan585_S5">S5: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> yeah <span class="overlap_tag 7">&lt;/7&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_39"><span class="line_no">PRpan585:39</span><span class="sid " id="src_PRpan585_u_39_PRpan585_S1">S1: </span><span class="utext"> because er: these are the <span class="pause"> (.) </span> you're you're just maybe recommending some certain approaches for the pharmacores- to overcome the <span class="overlap"><span class="overlap_tag">&lt;1&gt;</span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistance <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="overlap_tag 1">&lt;/1&gt;</span></span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_40"><span class="line_no">PRpan585:40</span><span class="sid " id="src_PRpan585_u_40_PRpan585_S5">S5: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;1&gt;</span> sure <span class="overlap_tag 1">&lt;/1&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_41"><span class="line_no">PRpan585:41</span><span class="sid " id="src_PRpan585_u_41_PRpan585_S1">S1: </span><span class="utext"> so but er: so the patient should already need to be <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistant <span class="pvc_tag"> &lt;/pvc&gt; </span></span> at that moment <span class="pause"> (.) </span> right?<span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_42"><span class="line_no">PRpan585:42</span><span class="sid " id="src_PRpan585_u_42_PRpan585_S5">S5: </span><span class="utext"><span class="other_continuation"> = </span> right.<span class="pause"> (1) </span> right so your question was whether it is possible to prevent the development of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pharmacoresistancy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> hh yeah of course that's another goal here and <span class="pause"> (.) </span> for instance if <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters are involved here?<span class="pause"> (.) </span> then prevention of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span> would be such strategy because if you prevent the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> BEFORE </span> the first treatment <span class="pause"> (.) </span> is an <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drug you would have another situation <span class="pause"> (.) </span> yes <span class="pause"> (.) </span> it might be <span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> possible <span class="overlap_tag 2">&lt;/2&gt;</span></span> but this is <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_43"><span class="line_no">PRpan585:43</span><span class="sid " id="src_PRpan585_u_43_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> yeah <span class="overlap_tag 2">&lt;/2&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_44"><span class="line_no">PRpan585:44</span><span class="sid " id="src_PRpan585_u_44_PRpan585_S5">S5: </span><span class="utext"> true speculas- <span class="pause"> (.) </span> pu:re speculation we <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_45"><span class="line_no">PRpan585:45</span><span class="sid " id="src_PRpan585_u_45_PRpan585_S1">S1: </span><span class="utext"><span class="other_continuation"> = </span> okay <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_46"><span class="line_no">PRpan585:46</span><span class="sid " id="src_PRpan585_u_46_PRpan585_S5">S5: </span><span class="utext"><span class="other_continuation"> = </span> don't know whether it's <span class="pause"> (.) </span> clinically feasible  </span></div>
         
         <div class="u " id="PRpan585_u_47"><span class="line_no">PRpan585:47</span><span class="sid " id="src_PRpan585_u_47_PRpan585_S1">S1: </span><span class="utext"> okay thanks <span class="pause"> (.) </span> please  </span></div>
         
         <div class="u " id="PRpan585_u_48"><span class="line_no">PRpan585:48</span><span class="sid " id="src_PRpan585_u_48_PRpan585_S6">S6: </span><span class="utext"> er you propose er inhibitors of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> (protein)  transporters <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> the the effect <span class="pause"> (.) </span> erm but this <span class="pause"> (.) </span> would give the possibility of the risk of er <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> toxicity for other er: er  (signify) <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> er what about the alternative way to: to design drugs w- which are not <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> sub<span class="overlap"><span class="overlap_tag">&lt;3&gt;</span>strated <span class="overlap_tag 3">&lt;/3&gt;</span></span><span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_49"><span class="line_no">PRpan585:49</span><span class="sid " id="src_PRpan585_u_49_PRpan585_S5">S5: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;3&gt;</span> right <span class="overlap_tag 3">&lt;/3&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_50"><span class="line_no">PRpan585:50</span><span class="sid " id="src_PRpan585_u_50_PRpan585_S6">S6: </span><span class="utext"> of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_51"><span class="line_no">PRpan585:51</span><span class="sid " id="src_PRpan585_u_51_PRpan585_S5">S5: </span><span class="utext"><span class="other_continuation"> = </span> right <span class="pause"> (.) </span> erm to the first part of your question <span class="pause"> (.) </span> this would only <span class="pause"> (.) </span> be true if one would ad- <span class="emph"> AD</span>minister the: er:m inhibitors on a chronic basis <span class="pause"> (.) </span> but that's not the idea the idea is hh that <span class="emph"> IF </span> the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drugs <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters is a  is seizure and use tra- transit phenomenon <span class="pause"> (.) </span> so that might be possible just by a <span class="emph"> SHORT </span> treatment period with an inhibitor <span class="pause"> (.) </span> to bring them down and then start hh with the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drug or give the combination <span class="pause"> (.) </span> erm the second part <span class="pause"> (.) </span> er this is already done er by pharmaceutical industry <span class="pause"> (.) </span> this probably here is of course you can select drugs which are not <span class="pause"> (.) </span> erm substrates for one of the known transporters <span class="pause"> (.) </span> but i bet there are many more transporters we which we are not aware of <span class="pause"> (.) </span> that's absolutely not possible is that <span class="pause"> (.) </span> every year m:ore transporters are <span class="emph"> DE</span>scribed so the same cell is using <span class="pause"> (.) </span> probably ten or more transporters in a <span class="emph"> ROW </span> to protect <span class="pause"> (.) </span> itself <span class="pause"> (.) </span> th- but there is another possibility which i did not mention <span class="pause"> (.) </span> which is to <span class="pause"> (.) </span> target <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drugs in way  to the brain <span class="pause"> (.) </span> by which you can <span class="pause"> (.) </span> surpass or <span class="pause"> (.) </span> bypass the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters and this is the liposome <span class="pause"> (.) </span> erm <span class="pause"> (.) </span> hypothesis that you <span class="pause"> (.) </span> in a way <span class="pause"> (.) </span><span class="emph"> PACK </span> the the drug in liposomes and the liposomes <span class="pause"> (.) </span> have antibodies?<span class="pause"> (.) </span> for certain particles in the brain so you have a brain-targeted liposome <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> anti-epileptic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> drug preparation <span class="pause"> (.) </span> and at least <span class="pause"> (.) </span> in animals this works <span class="pause"> (.) </span> that <span class="pause"> (.) </span> might <span class="emph"> EVEN </span> be another strategy without <span class="pause"> (.) </span> inhibiting the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> transporters <span class="pause"> (.) </span> bypassing them <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_52"><span class="line_no">PRpan585:52</span><span class="sid " id="src_PRpan585_u_52_PRpan585_S7">S7: </span><span class="utext"> [S5]  have you any idea why only part of the experimental er animals <span class="pause"> (.) </span> have an <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overexpression <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> of this <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> multi-drug <span class="pvc_tag"> &lt;/pvc&gt; </span></span> tran- transporter system.<span class="pause"> (.) </span> because this is clinically relevant <span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> because we have to <span class="overlap_tag 4">&lt;/4&gt;</span></span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_53"><span class="line_no">PRpan585:53</span><span class="sid " id="src_PRpan585_u_53_PRpan585_S5">S5: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> of course <span class="overlap_tag 4">&lt;/4&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_54"><span class="line_no">PRpan585:54</span><span class="sid " id="src_PRpan585_u_54_PRpan585_S7">S7: </span><span class="utext"> identify the patients of risk </span></div>
         
         <div class="u " id="PRpan585_u_55"><span class="line_no">PRpan585:55</span><span class="sid " id="src_PRpan585_u_55_PRpan585_S5">S5: </span><span class="utext"><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> that is of of <span class="overlap_tag 5">&lt;/5&gt;</span></span> course the reason why we started to do <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_56"><span class="line_no">PRpan585:56</span><span class="sid " id="src_PRpan585_u_56_PRpan585_S7">S7: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> and this is <span class="pause"> (.) </span> yeah <span class="overlap_tag 5">&lt;/5&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_57"><span class="line_no">PRpan585:57</span><span class="sid " id="src_PRpan585_u_57_PRpan585_S5">S5: </span><span class="utext"> er:m molecular genetics <span class="pause"> (.) </span> er the only explanation because these <span class="pause"> (.) </span> this is one <span class="emph"> RAT </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> strang <span class="ipa"><span class="ipa_tag"> &lt;ipa&gt; </span>stræŋ<span class="ipa_tag"> &lt;/ipa&gt; </span></span><span class="pvc_tag"> &lt;/pvc&gt; </span></span></span></div>
         
         <div class="u " id="PRpan585_u_58"><span class="line_no">PRpan585:58</span><span class="sid " id="src_PRpan585_u_58_PRpan585_S7">S7: </span><span class="utext"> mhm <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_59"><span class="line_no">PRpan585:59</span><span class="sid " id="src_PRpan585_u_59_PRpan585_S5">S5: </span><span class="utext"><span class="other_continuation"> = </span> so if we could select two subgroups the only explanation is <span class="pause"> (.) </span> variation in the genome of these animals.<span class="pause"> (.) </span> hh so we have several strategies here one is <span class="pause"> (.) </span><span class="emph"> BREEDING </span> the subgroups <span class="pause"> (.) </span> so inbreeding of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span> versus inbreeding of of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> non-responders <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> and then we do these <span class="pause"> (.) </span> erm gene <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> polymorphism <span class="pvc_tag"> &lt;/pvc&gt; </span></span> study?<span class="pause"> (.) </span> and genome ray studies so <span class="pause"> (1) </span> we <span class="emph"> HOPE </span> that we can <span class="pause"> (.) </span> identify genes which are <span class="pause"> (.) </span> underlying this phenomenon <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_60"><span class="line_no">PRpan585:60</span><span class="sid " id="src_PRpan585_u_60_PRpan585_S1">S1: </span><span class="utext"><span class="smode">&lt;soft&gt;</span> okay <span class="smode">&lt;/soft&gt;</span> if there is not any more questions thank you for this presentation again <span class="pause"> (.) </span> now we'll move up  to the third presentation doctor  [S8]  [S8/last]  from  [place2]  she will talk about in<span class="emph">TER</span>ference via network involvement during <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (5) </span></span></div>
         
         <div class="u " id="PRpan585_u_61"><span class="line_no">PRpan585:61</span><span class="sid " id="src_PRpan585_u_61_PRpan585_S8">S8: </span><span class="utext"> i would like first to thank  [S1]  [S1/last]  t- for having invited me to talk in this session <span class="pause"> (2) </span><span class="smode">&lt;soft&gt;</span> okay <span class="smode">&lt;/soft&gt;</span><span class="pause"> (2) </span> so my first slide of introduction on of on human temporal <span class="pause"> (.) </span> epilepsy the introduction has been mailed i- made in a detailed way of writing so i('m)  not going to <span class="pause"> (.) </span> this <span class="pause"> (.) </span> slide and <span class="pause"> (.) </span> i will immediately move to the second one <span class="pause"> (.) </span> which <span class="pause"> (.) </span> er: are  er what i feel <span class="pause"> (.) </span> the issues that are still <span class="pause"> (.) </span> unsolved in human temporal lobe epilepsy <span class="pause"> (.) </span> er the problem is that in <span class="emph"> HUMANS </span> the disease is only diagnosed <span class="pause"> (.) </span><span class="emph"> WHEN </span><span class="pause"> (.) </span> spontaneous seizures have already occurred.<span class="pause"> (.) </span> hh and the whole of the latent phase <span class="pause"> (.) </span> and the nature o- of events occurring are not fully understood <span class="pause"> (1) </span> and finally also what we try to ask is a respective role of the structures involved at the different phases of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> process <span class="pause"> (.) </span> to try to better understand the disease <span class="pause"> (2) </span> er f- to study <span class="pause"> (.) </span> this <span class="pause"> (.) </span> er questions we have chosen to work <span class="pause"> (.) </span> on one model which is a lithium-<span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span>pilocarpine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> model of epilepsy <span class="pause"> (.) </span> er which has a temporal sequence which is close to: that encounter the human temporal  (lobe)  epilepsy the acute phase is status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> during the latent phase there is no clinical or  <span class="spel_tag">&lt;spel&gt;</span> e e g  <span class="spel_tag">&lt;/spel&gt;</span> signs <span class="pause"> (.) </span> and there is <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuronal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> damage occurring in the hippocampus and mainly <span class="pause"> (.) </span> by <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortexes <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> thalamus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> reorganization <span class="pause"> (.) </span> i have <span class="emph"> NOT </span> illustrated this here?<span class="pause"> (.) </span> but the er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis that we see in lithio- lithium-<span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span>pilocarpine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> model of epilepsy is <span class="emph"> VERY </span> close to that seen in human temporal  (lobe)  epilepsy <span class="pause"> (.) </span> which means that we have major cell loss in  <span class="spel_tag">&lt;spel&gt;</span> c  <span class="spel_tag">&lt;/spel&gt;</span> one pyramidal neurons and in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> neurons <span class="pause"> (.) </span> we have moderate loss in  (serotonin)  neurons <span class="pause"> (.) </span> and we have a quite good preservation of  <span class="spel_tag">&lt;spel&gt;</span> c a  <span class="spel_tag">&lt;/spel&gt;</span> two and granule cell the granule cell layer and some dispersion of  (granule)  cells <span class="pause"> (.) </span> and finally we have a chronic phase <span class="pause"> (.) </span> during which spontaneous <span class="pause"> (.) </span> recurrent seizures can be recorded and they last for <span class="emph"> THE </span><span class="emph"> WHOLE </span> lifetime of the animals.<span class="pause"> (.) </span> this model is interesting for another reason <span class="pause"> (.) </span> is that there are age-dependent changes <span class="pause"> (.) </span> which means that in adult rats <span class="pause"> (.) </span> when where in fact when you induce status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in adult rats <span class="pause"> (.) </span> you will <span class="pause"> (.) </span> have extended <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuronal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> dimension as i described before hh and one hundred per cent of the population of rats <span class="pause"> (.) </span> will become epileptic after a latent phase of amelioration of usually fourteen to twenty-five days <span class="pause"> (1) </span> in  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats <span class="pause"> (.) </span> which is <span class="pause"> (.) </span> the matu- equivalent <span class="pause"> (.) </span> more or less to the maturation of a nine to ten year old child <span class="pause"> (.) </span> we have limited <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuronal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> dimension. and about seventy to eighty per cent of the rats will become epileptic but after a much longer latent phase which is a bit
               a little bit longer than two months <span class="pause"> (.) </span> and if we use  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> ten? rats <span class="pause"> (.) </span> which is corresponding to is <span class="emph"> FULL</span>-term human newborn <span class="pause"> (.) </span> we have no  (lesion)  and no epilepsy <span class="pause"> (.) </span> so we have tried to use <span class="pause"> (.) </span> these different ages to understand the process <span class="emph"> AND </span> the data i will present today concern only adult and  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats <span class="pause"> (1) </span> er <span class="pause"> (.) </span> just b:riefly to go over the techniques we used <span class="pause"> (.) </span> we induced <span class="pause"> (.) </span> er status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> with lithium  (chloride)  for all twenty hours later but different <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> dosis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pilocarpine <span class="pvc_tag"> &lt;/pvc&gt; </span></span> according to age <span class="pause"> (.) </span> we have measured several glucose utilization using two <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> glucose <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> (geography)  during <span class="pause"> (.) </span> all the different phases <span class="pause"> (.) </span> of the disease.<span class="pause"> (.) </span> we have done histopathology <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (restaining) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> (staining) <span class="pause"> (.) </span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuronal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cell counting between twenty-four hours and four months <span class="pause"> (.) </span> we have used  <span class="spel_tag">&lt;spel&gt;</span> m r i t  <span class="spel_tag">&lt;/spel&gt;</span> two rated images with a magnet of four point seven <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> tesla <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and we have performed that from <span class="pause"> (.) </span> status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> to the onset of <span class="pause"> (.) </span> er the <span class="pause"> (.) </span> of the epilepsy and even during epilepsy <span class="pause"> (.) </span> we have recorded  <span class="spel_tag">&lt;spel&gt;</span> e e g  <span class="spel_tag">&lt;/spel&gt;</span> and done some video recording <span class="pause"> (.) </span> to er:<span class="pause"> (.) </span> detect the onset of <span class="pause"> (.) </span> er spontaneous seizures <span class="pause"> (.) </span> and we have been using <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroprotection <span class="pvc_tag"> &lt;/pvc&gt; </span></span> strategies <span class="pause"> (.) </span> so first i will <span class="pause"> (.) </span> present to you our data on <span class="pause"> (.) </span> the <span class="pause"> (.) </span> er  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> study in adult rats <span class="pause"> (1) </span> here are the images we have got so this is the same rat for all during the <span class="emph"> WHOLE </span> process </span></div>
         
         
         <div class="gap">(gap 00:13:30) <span>{mon; S8 continues presenting the experiment}</span></div>
         
         
         <div class="u " id="PRpan585_u_62"><span class="line_no">PRpan585:62</span><span class="sid " id="src_PRpan585_u_62_PRpan585_S8">S8: </span><span class="utext"> in <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> hh and <span class="pause"> (.) </span> what we see <span class="emph"> HERE </span> is we have some decreasing the rates of glucose utilization and some <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuronal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> loss but there is nothing striking in this  animals <span class="pause"> (1) </span> if we look at <span class="pause"> (.) </span><span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty rat one rats  that <span class="emph"> HAVE </span> become epileptic <span class="pause"> (.) </span> what is very striking is what occurs here in the high loss <span class="pause"> (.) </span> we have <span class="pause"> (1) </span> a lot <span class="pause"> (.) </span> we have fifty per cent cell loss <span class="pause"> (.) </span> but <span class="pause"> (.) </span> this  structures <span class="pause"> (.) </span> has  still a normal metabolism <span class="pause"> (.) </span> so obviously something is going on <span class="emph"> HERE </span> at the moment we don't know <span class="pause"> (.) </span> if the neurons are <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hypermetabolic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> or if it's due to <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> cells <span class="pause"> (.) </span> but at least <span class="pause"> (.) </span> this structure <span class="pause"> (.) </span> is <span class="pause"> (1) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> overactivated <span class="pvc_tag"> &lt;/pvc&gt; </span></span> in some way.<span class="pause"> (1) </span> if we look at epileptic adult rats <span class="pause"> (.) </span> then we see the <span class="emph"> SAME </span> phenomenon in the high loss <span class="pause"> (.) </span> which is paralleled <span class="pause"> (.) </span> by the same phenomenon <span class="pause"> (.) </span> in the  (peripheral)  cortex while the other areas <span class="pause"> (.) </span> don't show <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> subtype <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of discrepancy <span class="pause"> (1) </span> so here is just the summary <span class="pause"> (.) </span> of the data the data which i showed <span class="pause"> (1) </span><span class="vocal">&lt;smacks lips&gt;</span> so <span class="pause"> (1) </span> what what we can see is that <span class="pause"> (.) </span> at the end of the latent phase <span class="pause"> (.) </span> which are data i didn't show? and during the chronic phase which you just <span class="emph"> SAW </span><span class="pause"> (.) </span> we have a relative <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hypermetabolism <span class="pvc_tag"> &lt;/pvc&gt; </span></span> which is only present in the high loss in  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats <span class="pause"> (.) </span> and which is which is present in the high loss and  (peripheral)  cortex in adult rats <span class="pause"> (.) </span> which <span class="emph"> POINTS </span> to a key role of the high loss in the genesis and <span class="emph"> MAINTENANCE </span> of spontaneous recurrent seizures <span class="pause"> (1) </span> so i am going now to my conclusions <span class="pause"> (.) </span> so what we <span class="pause"> (.) </span> what we have seen <span class="pause"> (.) </span> is that during the acute phase <span class="pause"> (.) </span> the early lesion of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> entorhinal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortexes <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> seems to be critical for the development of the <span class="pause"> (.) </span> epilepsy <span class="pause"> (1) </span> since in  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats <span class="pause"> (.) </span> if we don't see these early  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> signal we will not have any epilepsy <span class="pause"> (.) </span> later on <span class="pause"> (.) </span> during the latent and chronic phase the relative hyperactivity of the high loss of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> (virus) <span class="pause"> (.) </span> could be a f- key factor <span class="pause"> (.) </span> for the initiation and maintenance of spontaneous seizures and some other structures may participate too like the  (peripheral)  cortex <span class="pause"> (.) </span> in adult rats <span class="pause"> (.) </span> and what are the strategies i would <span class="pause"> (.) </span> suggest to try to <span class="pause"> (.) </span> better <span class="pause"> (.) </span> understand and follow <span class="pause"> (.) </span> on <span class="pause"> (.) </span> er this topic?<span class="pause"> (1) </span> er we have now er try we we are trying to extend our search <span class="pause"> (.) </span> of surrogate markers <span class="pause"> (1) </span> er <span class="pause"> (.) </span> we: we have started a collaboration with  [first name2]  [last name2]  at  [name1]  in the  [place3] <span class="pause"> (.) </span> er  er trying to identify <span class="pause"> (.) </span> other markers <span class="pause"> (.) </span> er in this pet  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats <span class="pause"> (.) </span> er using  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> non-invasive <span class="pause"> (.) </span> er non-invasive imaging techniques <span class="pause"> (.) </span> because <span class="pause"> (.) </span> as you may have seen or may remember <span class="pause"> (.) </span> i have shown that we have an early signal in <span class="pause"> (.) </span><span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one rats but this signal is only lasting for twenty-four hours <span class="pause"> (.) </span> which is a kind of short if you <span class="pause"> (.) </span> want to try to apply this  techniques to <span class="pause"> (.) </span> er children <span class="pause"> (.) </span> that have for example com- -plex febrile seizures <span class="pause"> (.) </span> and they need some time to be brought to the clinic and some time to be <span class="pause"> (.) </span> er examined <span class="pause"> (.) </span> so we would like to <span class="pause"> (.) </span> be able to <span class="pause"> (.) </span> identify <span class="pause"> (.) </span> other surrogate markers <span class="pause"> (.) </span> that will last maybe a little bit longer <span class="pause"> (.) </span> to allow to be applied <span class="pause"> (.) </span> to the <span class="pause"> (.) </span> er human population and <span class="pause"> (.) </span> maybe <span class="pause"> (.) </span> allow us to identify groups at risk for temporal lobe epilepsy <span class="pause"> (.) </span> hh an alternative way <span class="pause"> (.) </span> of er <span class="pause"> (.) </span> trying to <span class="pause"> (.) </span> modify <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> would be <span class="pause"> (.) </span> to er be able to identify drugs <span class="pause"> (.) </span> that <span class="pause"> (.) </span> can <span class="pause"> (.) </span> er: have a disease-modifying effect <span class="pause"> (.) </span> as we saw for <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> for example <span class="pause"> (.) </span> which means drugs that <span class="pause"> (.) </span> would be able <span class="smode">&lt;slow&gt;</span> to change <span class="smode">&lt;/slow&gt;</span><span class="pause"> (.) </span> the process <span class="pause"> (.) </span> early enough <span class="pause"> (.) </span> to prevent <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and maybe <span class="pause"> (.) </span> er try to be <span class="pause"> (.) </span> try to <span class="pause"> (1) </span> then in that case <span class="pause"> (.) </span> we wouldn't <span class="pause"> (.) </span> we wouldn't need <span class="pause"> (.) </span> to select the population <span class="pause"> (.) </span> but in <span class="pause"> (.) </span> for example in the population <span class="pause"> (.) </span> of <span class="pause"> (.) </span> er:<span class="pause"> (1) </span> infants with complex febrile seizure we could decide to apply it could be decided to apply <span class="pause"> (.) </span> this <span class="pause"> (.) </span> type of strategy for i don't know it would <span class="pause"> (.) </span> be a duration that would have been to be  discussed but for some <span class="pause"> (.) </span> period <span class="pause"> (.) </span> to <span class="pause"> (.) </span> prevent and stop <span class="pause"> (.) </span> the process.<span class="pause"> (1) </span> and <span class="pause"> (.) </span> to finish <span class="pause"> (.) </span> i <span class="pause"> (.) </span> would like to thank <span class="pause"> (.) </span> er the part of my team who has been participating in that work?<span class="pause"> (.) </span> as well as my collaborators <span class="pause"> (.) </span> at the <span class="pause"> (.) </span> er biological physic institute fo:r the  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> collaboration and i thank you for your attention  </span></div>
         
         <div class="u " id="PRpan585_u_63"><span class="line_no">PRpan585:63</span><span class="sid " id="src_PRpan585_u_63_PRpan585_SS">SS: </span><span class="utext"><span class="vocal">&lt;applauds&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_64"><span class="line_no">PRpan585:64</span><span class="sid " id="src_PRpan585_u_64_PRpan585_S1">S1: </span><span class="utext"> thank you very much for this excellent er presentation doctor  [S8/last] <span class="pause"> (.) </span> are there any com<span class="emph">ME</span>nts? please </span></div>
         
         <div class="u " id="PRpan585_u_65"><span class="line_no">PRpan585:65</span><span class="sid " id="src_PRpan585_u_65_PRpan585_S9">S9: </span><span class="utext"> what was the rationale to test caffeine?<span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_66"><span class="line_no">PRpan585:66</span><span class="sid " id="src_PRpan585_u_66_PRpan585_S8">S8: </span><span class="utext"> what was rationale for to test caffeine <span class="pause"> (.) </span> er it was <span class="pause"> (.) </span> because er <span class="pause"> (.) </span> caffeine? first of all. caffeine has been shown to er <span class="pause"> (.) </span> be an antagonist of <span class="pause"> (.) </span><span class="smode">&lt;soft&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> receptors <span class="smode">&lt;/soft&gt;</span><span class="pause"> (.) </span> and so to <span class="pause"> (.) </span> work on the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neurotransmission <span class="pvc_tag"> &lt;/pvc&gt; </span></span> was <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> and also because  we er have seen in the literature that <span class="pause"> (.) </span> er caffeine had has er <span class="pause"> (1) </span> bi- <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> biphysical <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> not <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> biphysic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> but has a different effect if you use high doses.<span class="pause"> (.) </span> is an antagonist of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> receptors.<span class="pause"> (.) </span> saying you increase exaltation and it's <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> but interestingly  (now)  the group of <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> showed <span class="pause"> (.) </span> that <span class="pause"> (.) </span> using it at the level of hu- the normal human consumption and putting it in drinking water <span class="pause"> (.) </span> in fact it <span class="emph"> WAS </span> protective <span class="pause"> (.) </span> in a model of <span class="pause"> (.) </span> er  (neonatal)  er  (hypoxia on) <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> so that's the reason why?<span class="pause"> (.) </span> we decided to see if this <span class="pause"> (.) </span> type of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroprotection <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of low doses of caffeine could be <span class="pause"> (.) </span> could extend to epi<span class="emph">LE</span>psy and it <span class="emph"> SEEMS </span> at least <span class="pause"> (.) </span> to protect it's not worth <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> (the lesions) <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_67"><span class="line_no">PRpan585:67</span><span class="sid " id="src_PRpan585_u_67_PRpan585_S9">S9: </span><span class="utext"><span class="vocal">&lt;smacks lips&gt;</span> erm what do you think er are the reasons for the <span class="pause"> (.) </span> differences <span class="pause"> (.) </span> in: er selectivity of er protection there are big differences between the different substances you used <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_68"><span class="line_no">PRpan585:68</span><span class="sid " id="src_PRpan585_u_68_PRpan585_S8">S8: </span><span class="utext"> er sorry i didn't hear the er the second part of your question the second part of your <span class="overlap"><span class="overlap_tag">&lt;6&gt;</span> question <span class="overlap_tag 6">&lt;/6&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_69"><span class="line_no">PRpan585:69</span><span class="sid " id="src_PRpan585_u_69_PRpan585_S9">S9: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;6&gt;</span> er <span class="overlap_tag 6">&lt;/6&gt;</span></span> you found <span class="pause"> (.) </span> er:m very impressive differences <span class="pause"> (.) </span> er:m <span class="pause"> (.) </span> between the different substances you used?<span class="pause"> (.) </span> according to: selectivity of protection <span class="pause"> (.) </span> and what do you think are the reasons <span class="pause"> (1) </span></span></div>
         
         <div class="u " id="PRpan585_u_70"><span class="line_no">PRpan585:70</span><span class="sid " id="src_PRpan585_u_70_PRpan585_S8">S8: </span><span class="utext"> hh in fact this is this is very <span class="pause"> (.) </span> i i have in fact i i can tell you right away that i have no answer to that question. i i try to go to to the literature and try to <span class="pause"> (.) </span> er <span class="vocal">&lt;smacks lips&gt;</span> make <span class="pause"> (.) </span> an update of the er er: different works that have been done <span class="pause"> (.) </span> er on <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuroprotection <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenesis <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> and er: what <span class="emph"> I </span> have found is that <span class="pause"> (.) </span><span class="emph"> YOU </span> have positive or negative results <span class="pause"> (.) </span> hh er <span class="pause"> (.) </span> in <span class="pause"> (.) </span> with different drugs working on different pathways  so you have you have positive and negative results with <span class="pause"> (.) </span> with drugs working on the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> biogic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> system <span class="pause"> (.) </span> on the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> glutamatergic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> system <span class="pause"> (.) </span> on sodium channels on calcium channels et cetera <span class="pause"> (.) </span> so at: the moment i'm i'm totally puzzled <span class="pause"> (.) </span> by what what we f:ind and <span class="pause"> (1) </span> as i as i told you i have no direct answer i <span class="pause"> (.) </span><span class="emph"> REALLY </span> i don't know it's it's still <span class="pause"> (.) </span> w- we still need to think <span class="pause"> (.) </span> quite a lot about that and er the the difference <span class="emph"> MIGHT </span><span class="pause"> (.) </span> also be er related to the different properties <span class="pause"> (.) </span> of <span class="pause"> (.) </span> the different brain areas <span class="pause"> (.) </span> and er:<span class="pause"> (1) </span> this are this are things i guess we we still need to <span class="pause"> (.) </span> deepen a bit more what what makes <span class="pause"> (.) </span> for example this the <span class="pause"> (2) </span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortexes <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> SO </span> vulnerable <span class="emph"> SO </span> early <span class="pause"> (.) </span> in the process <span class="pause"> (.) </span> compared to hippocampus for example.<span class="pause"> (.) </span> or <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> thalamus <span class="pvc_tag"> &lt;/pvc&gt; </span></span> are also <span class="pause"> (.) </span> er vulnerable quite early <span class="pause"> (.) </span> but not to the same extent  as <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortexes <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> so there are <span class="pause"> (.) </span> a lot of <span class="pause"> (.) </span> er underlying molecular mechanism  which we still need to understand <span class="pause"> (5) </span></span></div>
         
         <div class="u " id="PRpan585_u_71"><span class="line_no">PRpan585:71</span><span class="sid " id="src_PRpan585_u_71_PRpan585_S10">S10: </span><span class="utext"> i just <span class="pause"> (.) </span> wondering the:<span class="pause"> (.) </span> you <span class="pause"> (.) </span> you take the er <span class="pause"> (.) </span> er <span class="pause"> (1) </span> damage the er of the area <span class="pause"> (.) </span> correlated with the severity of the s:eizure how frequent were  (signals)  in your model and how it correlate(d)  with the signals in the  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span><span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_72"><span class="line_no">PRpan585:72</span><span class="sid " id="src_PRpan585_u_72_PRpan585_S8">S8: </span><span class="utext"> er:</span></div>
         
         <div class="u " id="PRpan585_u_73"><span class="line_no">PRpan585:73</span><span class="sid " id="src_PRpan585_u_73_PRpan585_S10">S10: </span><span class="utext"> looks like uniform group that's how you presented <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_74"><span class="line_no">PRpan585:74</span><span class="sid " id="src_PRpan585_u_74_PRpan585_S8">S8: </span><span class="utext"> you mean at which at w- er <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_75"><span class="line_no">PRpan585:75</span><span class="sid " id="src_PRpan585_u_75_PRpan585_S1">S1: </span><span class="utext"><span class="other_continuation"> = </span> seizures severity <span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> does <span class="overlap_tag 7">&lt;/7&gt;</span></span> seizure severity correlates with the  <span class="spel_tag">&lt;spel&gt;</span> m r  <span class="spel_tag">&lt;/spel&gt;</span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_76"><span class="line_no">PRpan585:76</span><span class="sid " id="src_PRpan585_u_76_PRpan585_S8">S8: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> se- <span class="overlap_tag 7">&lt;/7&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_77"><span class="line_no">PRpan585:77</span><span class="sid " id="src_PRpan585_u_77_PRpan585_S1">S1: </span><span class="utext"> er <span class="overlap"><span class="overlap_tag">&lt;1&gt;</span> signal <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap_tag 1">&lt;/1&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_78"><span class="line_no">PRpan585:78</span><span class="sid " id="src_PRpan585_u_78_PRpan585_S10">S10: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;1&gt;</span> with with <span class="overlap_tag 1">&lt;/1&gt;</span></span> the  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> signal <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_79"><span class="line_no">PRpan585:79</span><span class="sid " id="src_PRpan585_u_79_PRpan585_S8">S8: </span><span class="utext"><span class="other_continuation"> = </span> you mean you mean seizure the  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> signal at which at which time <span class="pause"> (.) </span> at during status <span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> later <span class="overlap_tag 2">&lt;/2&gt;</span></span> er </span></div>
         
         <div class="u " id="PRpan585_u_80"><span class="line_no">PRpan585:80</span><span class="sid " id="src_PRpan585_u_80_PRpan585_S10">S10: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> n- <span class="overlap_tag 2">&lt;/2&gt;</span></span> no i mean erm er erm er yeah i'm yah i'm i'm talking about er the signal i mean after status <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_81"><span class="line_no">PRpan585:81</span><span class="sid " id="src_PRpan585_u_81_PRpan585_S8">S8: </span><span class="utext"> after status <span class="pause"> (.) </span> er: we could not make in fact we could not make any correlation <span class="pause"> (.) </span> between <span class="pause"> (.) </span> the severity or the frequency of the seizure and the  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> signal.<span class="pause"> (1) </span> so it n- there is there is no obvious <span class="pause"> (.) </span> correlation <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_82"><span class="line_no">PRpan585:82</span><span class="sid " id="src_PRpan585_u_82_PRpan585_S11">S11: </span><span class="utext"> er what might be the <span class="pause"> (.) </span> the: reason for this big differences between this ages in in glucose utilization during the <span class="pause"> (.) </span> status and after that <span class="pause"> (1) </span></span></div>
         
         <div class="u " id="PRpan585_u_83"><span class="line_no">PRpan585:83</span><span class="sid " id="src_PRpan585_u_83_PRpan585_S8">S8: </span><span class="utext"> the i'm sorry i must <span class="overlap"><span class="overlap_tag">&lt;3&gt;</span> become <span class="overlap_tag 3">&lt;/3&gt;</span></span> deaf <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_84"><span class="line_no">PRpan585:84</span><span class="sid " id="src_PRpan585_u_84_PRpan585_S11">S11: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;3&gt;</span> ah <span class="overlap_tag 3">&lt;/3&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_85"><span class="line_no">PRpan585:85</span><span class="sid " id="src_PRpan585_u_85_PRpan585_S8">S8: </span><span class="utext"> but i don't  (understand) <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_86"><span class="line_no">PRpan585:86</span><span class="sid " id="src_PRpan585_u_86_PRpan585_S11">S11: </span><span class="utext"><span class="other_continuation"> = </span> what might be the <span class="pause"> (.) </span><span class="emph"> REASON </span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_87"><span class="line_no">PRpan585:87</span><span class="sid " id="src_PRpan585_u_87_PRpan585_S8">S8: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> yes?<span class="overlap_tag 4">&lt;/4&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_88"><span class="line_no">PRpan585:88</span><span class="sid " id="src_PRpan585_u_88_PRpan585_S11">S11: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> for <span class="overlap_tag 4">&lt;/4&gt;</span></span> the glucose utilization <span class="pause"> (.) </span> or the differences between different <span class="emph"> AGES </span><span class="pause"> (.) </span> in status <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepticus.<span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_89"><span class="line_no">PRpan585:89</span><span class="sid " id="src_PRpan585_u_89_PRpan585_S8">S8: </span><span class="utext"> you mean dur- <span class="pause"> (.) </span> during status?</span></div>
         
         <div class="u " id="PRpan585_u_90"><span class="line_no">PRpan585:90</span><span class="sid " id="src_PRpan585_u_90_PRpan585_S11">S11: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> yes <span class="overlap_tag 5">&lt;/5&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_91"><span class="line_no">PRpan585:91</span><span class="sid " id="src_PRpan585_u_91_PRpan585_S8">S8: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;5&gt;</span> mhm <span class="overlap_tag 5">&lt;/5&gt;</span></span> er:<span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_92"><span class="line_no">PRpan585:92</span><span class="sid " id="src_PRpan585_u_92_PRpan585_S8">S8: </span><span class="utext"> the reasons the er first first of all <span class="pause"> (.) </span> er <span class="pause"> (1) </span> you mean <span class="pause"> (1) </span> wha- what is exactly your questions is is it at  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> ten  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one?<span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_93"><span class="line_no">PRpan585:93</span><span class="sid " id="src_PRpan585_u_93_PRpan585_S11">S11: </span><span class="utext"><span class="other_continuation"> = </span> yeah <span class="pause"> (.) </span> yeah <span class="overlap"><span class="overlap_tag">&lt;6&gt;</span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="overlap_tag 6">&lt;/6&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_94"><span class="line_no">PRpan585:94</span><span class="sid " id="src_PRpan585_u_94_PRpan585_S8">S8: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;6&gt;</span> at <span class="overlap_tag 6">&lt;/6&gt;</span></span> the three different ages you <span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> you <span class="overlap_tag 7">&lt;/7&gt;</span></span><span class="smode">&lt;soft&gt;</span> okay <span class="smode">&lt;/soft&gt;</span><span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_95"><span class="line_no">PRpan585:95</span><span class="sid " id="src_PRpan585_u_95_PRpan585_S11">S11: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;7&gt;</span> yes <span class="overlap_tag 7">&lt;/7&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_96"><span class="line_no">PRpan585:96</span><span class="sid " id="src_PRpan585_u_96_PRpan585_S8">S8: </span><span class="utext"> er:<span class="pause"> (1) </span> at <span class="pause"> (.) </span> at  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> ten?<span class="pause"> (1) </span> the:<span class="pause"> (.) </span> basal level of glucose utilization are  very low <span class="pause"> (.) </span> it it was difficult to see <span class="smode">&lt;slow&gt;</span> on my slide <span class="smode">&lt;/slow&gt;</span> because <span class="pause"> (.) </span> er we had to shrink <span class="pause"> (.) </span> the: the scale <span class="pause"> (.) </span> because of the large <span class="pause"> (.) </span> increase in glucose utilization but if you see it normally <span class="pause"> (.) </span> you have <span class="pause"> (.) </span> er <span class="pause"> (.) </span> levels of glucose utilization that are er: five to seven times lower than in another brain <span class="pause"> (.) </span> and er <span class="pause"> (.) </span> you <span class="pause"> (.) </span> at that age <span class="pause"> (.) </span> most of the enzymes of the er <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> oxidative <span class="pvc_tag"> &lt;/pvc&gt; </span></span> pathway  of glucose utilization are not fully developed <span class="pause"> (.) </span> so the that's the reason why glucose utilization cannot <span class="pause"> (.) </span> cannot be as effective <span class="pause"> (.) </span> er <span class="pause"> (.) </span> then again at  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twen- between pen-  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one and the other there is again a difference <span class="pause"> (.) </span> er <span class="pause"> (2) </span> probably parting into the <span class="pause"> (.) </span> er further development of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cytochrome <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> oxidase <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and phos- <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> oxidative <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> phosphor <span class="pvc_tag"> &lt;/pvc&gt; </span></span> relation <span class="pause"> (.) </span> er: during that age period  because you have a steep development between  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> twenty-one and  <span class="spel_tag">&lt;spel&gt;</span> p  <span class="spel_tag">&lt;/spel&gt;</span> thirty-five <span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_97"><span class="line_no">PRpan585:97</span><span class="sid " id="src_PRpan585_u_97_PRpan585_S1">S1: </span><span class="utext"> any more questions?<span class="pause"> (1) </span> so apparently we have now some data <span class="pause"> (.) </span> to identify the patients at risk <span class="pause"> (.) </span> this from animal data and you will for the  (progress)  for the er human <span class="pause"> (.) </span> studies <span class="pause"> (.) </span> and also we have to prevent especially the basal <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortexes <span class="pvc_tag"> &lt;/pvc&gt; </span></span> and high loss <span class="pause"> (.) </span> er to prevent epilepsy <span class="overlap"><span class="overlap_tag">&lt;1&gt;</span> er <span class="overlap_tag 1">&lt;/1&gt;</span></span> according to <span class="pause"> (1) </span></span></div>
         
         <div class="u " id="PRpan585_u_98"><span class="line_no">PRpan585:98</span><span class="sid " id="src_PRpan585_u_98_PRpan585_S8">S8: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;1&gt;</span> at leas- <span class="overlap_tag 1">&lt;/1&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_99"><span class="line_no">PRpan585:99</span><span class="sid " id="src_PRpan585_u_99_PRpan585_S1">S1: </span><span class="utext"> your studies </span></div>
         
         <div class="u " id="PRpan585_u_100"><span class="line_no">PRpan585:100</span><span class="sid " id="src_PRpan585_u_100_PRpan585_S8">S8: </span><span class="utext"> at least this seems to come out from <span class="pause"> (.) </span><span class="overlap"><span class="overlap_tag">&lt;8&gt;</span> this <span class="overlap_tag 8">&lt;/8&gt;</span></span> specific model </span></div>
         
         <div class="u " id="PRpan585_u_101"><span class="line_no">PRpan585:101</span><span class="sid " id="src_PRpan585_u_101_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;8&gt;</span> uhu <span class="overlap_tag 8">&lt;/8&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_102"><span class="line_no">PRpan585:102</span><span class="sid " id="src_PRpan585_u_102_PRpan585_S1">S1: </span><span class="utext"> okay thank you very much <span class="pause"> (.) </span> now we are moving up  to the last speaker?<span class="pause"> (.) </span> who is <span class="pause"> (.) </span> of course not the least one? [S12]  [S12/last] ? he will now tell us abou:t som:e new tricks maybe or tactics er: in terms of surgical approach <span class="pause"> (.) </span> to this er: epileptic type </span></div>
         
         <div class="u " id="PRpan585_u_103"><span class="line_no">PRpan585:103</span><span class="sid " id="src_PRpan585_u_103_PRpan585_S12">S12: </span><span class="utext"> thank you  [S1] <span class="pause"> (.) </span> with your <span class="pause"> (.) </span> permission i have little bit changed <span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> the <span class="overlap_tag 2">&lt;/2&gt;</span></span> the topic of my talk <span class="pause"> (.) </span></span></div>
         
         <div class="u " id="PRpan585_u_104"><span class="line_no">PRpan585:104</span><span class="sid " id="src_PRpan585_u_104_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;2&gt;</span> yes <span class="overlap_tag 2">&lt;/2&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_105"><span class="line_no">PRpan585:105</span><span class="sid " id="src_PRpan585_u_105_PRpan585_S12">S12: </span><span class="utext"> in order to: discuss with you about  the <span class="pause"> (.) </span> possibility of exploring <span class="pause"> (.) </span> new strategies <span class="pause"> (.) </span> in in epilepsy surgery of lesion temporal epilepsy <span class="pause"> (.) </span> so er by chance <span class="pause"> (.) </span> we also follow the  [S8]  [S8/last]  presentation <span class="pause"> (.) </span> and er what you have presented will be important to interpret what we can find <span class="pause"> (.) </span> in human beings <span class="pause"> (1) </span> er <span class="pause"> (.) </span> you know for in epilepsy er surgery  (history) <span class="pause"> (.) </span> it's clear <span class="pause"> (.) </span> that <span class="pause"> (1) </span> the:<span class="pause"> (.) </span> strategy of operation <span class="pause"> (.) </span> has evolved with time?<span class="pause"> (.) </span> in evolving this time it has also evolved with the con<span class="emph">CEPT </span><span class="pause"> (.) </span> we are behind surgery that is the <span class="pause"> (.) </span> ideal concept we have of <span class="pause"> (.) </span> the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> organization and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> area <span class="pause"> (.) </span> or zone <span class="pause"> (.) </span> and with the development of er <span class="pause"> (.) </span> er <span class="pause"> (.) </span> invasive exploration <span class="pause"> (.) </span> and <span class="pause"> (.) </span> of er the eighties and the nineties <span class="pause"> (.) </span> it was clear that er er with the development of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuropathology <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> er <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxxx <span class="un_tag">&lt;/un&gt;</span></span> and there will be  [place4] <span class="pause"> (.) </span> using <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> has enough argument to propose <span class="pause"> (.) </span> the first <span class="pause"> (.) </span> er selective <span class="pause"> (.) </span> surgery for <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> mesial <span class="pvc_tag"> &lt;/pvc&gt; </span></span> temporal epilepsy the so-called <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampectomy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> now it is with known risk <span class="pause"> (.) </span> with success <span class="pause"> (.) </span> and this is one of the <span class="pause"> (.) </span> of the first er er <span class="pause"> (.) </span> er  <span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> post- <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> post-surgical <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="spel_tag">&lt;spel&gt;</span> m r i.<span class="spel_tag">&lt;/spel&gt;</span><span class="pause"> (.) </span> but er <span class="pause"> (.) </span> was it is  (profitable)  operation here?<span class="pause"> (.) </span> and <span class="pause"> (.) </span> what was the second er wait <span class="pause"> (.) </span> excuse me for the bad quality that after the correlated <span class="pause"> (1) </span> er <span class="pause"> (.) </span> the rate of success <span class="pause"> (.) </span> in fact with the type of structures <span class="pause"> (.) </span> it had been <span class="pause"> (.) </span> removed by the selective <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span> hippo- <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampectomy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> AND </span> the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> which <span class="pause"> (.) </span> seems  seems to be <span class="pause"> (.) </span> very important <span class="pause"> (.) </span> indeed.<span class="pause"> (3) </span> later on <span class="pause"> (.) </span> er when er my colleague  [first name4]  [last name4]  began began er <span class="pause"> (.) </span> er exploring the possibility of gamma knife <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> radiosurgery <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> to <span class="pause"> (1) </span> achieve <span class="pause"> (1) </span> a <span class="pause"> (.) </span> selective <span class="pause"> (1) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampectomy <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="emph"> BUT </span><span class="pause"> (.) </span> non-invasively because it was <span class="pause"> (.) </span> by the the ways of er <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> radiosurgery <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (1) </span> in the first time well it is one of the <span class="pause"> (.) </span> early cases indeed in ninety-three i was not working with him at this time <span class="pause"> (.) </span> a:nd the dose were  relatively <span class="pause"> (.) </span> important and this is <span class="pause"> (.) </span> the <span class="pause"> (.) </span> model <span class="pause"> (.) </span> the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> post-surgical <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="spel_tag">&lt;spel&gt;</span> m r i  <span class="spel_tag">&lt;/spel&gt;</span> of a <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> amygdala <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampectomy <span class="pvc_tag"> &lt;/pvc&gt; </span></span> but done without er true surgery <span class="pause"> (1) </span> it was initial temporal  (lobe)  epilepsy <span class="pause"> (.) </span><span class="emph"> BUT </span><span class="pause"> (.) </span><span class="emph"> THIS </span><span class="pause"> (1) </span> operation <span class="pause"> (.) </span> had no significant effect <span class="pause"> (.) </span> on the patient's epilepsy <span class="pause"> (1) </span> and <span class="pause"> (.) </span> particular for me it's important that both surgical seizure  (and the)  simple <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (4) </span> later on we <span class="pause"> (.) </span> to understand and to try to cure this patient <span class="pause"> (1) </span> we implanted e- electrons <span class="pause"> (.) </span> at <span class="pause"> (.) </span> different levels and particularly <span class="pause"> (.) </span> in this <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> corte- <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> entorhinal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cortex <span class="pause"> (1) </span><span class="emph"> AND </span> in this patient it was <span class="pause"> (.) </span> really er interesting to see that the seizures <span class="pause"> (.) </span> we <span class="pause"> (.) </span> er <span class="pause"> (.) </span> could we got <span class="pause"> (1) </span> in fact <span class="pause"> (.) </span> arose <span class="pause"> (.) </span> for <span class="pause"> (.) </span> the entire <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> area from the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> entorhinal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cortex <span class="pause"> (.) </span> to er the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> area <span class="pause"> (.) </span> and back to the posterior hippocampus and <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> area <span class="pause"> (.) </span> so <span class="pause"> (.) </span> er she could <span class="pause"> (.) </span> er present the same epilepsy with the same symptoms <span class="pause"> (.) </span> but with  (discharge) <span class="pause"> (.) </span> rising <span class="emph"> ONLY </span><span class="pause"> (.) </span> from <span class="pause"> (.) </span> the <span class="pause"> (.) </span> (prior) <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> (valid) <span class="pause"> (.) </span><span class="vocal">&lt;smacks lips&gt;</span> this er <span class="pause"> (.) </span> other arguments <span class="pause"> (.) </span> from experimental models <span class="pause"> (.) </span> in from <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuropathology <span class="pvc_tag"> &lt;/pvc&gt; </span></span> because <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis is also <span class="pause"> (.) </span> called <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> mesiotemporal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> sclerosis we know <span class="emph"> THAT </span><span class="pause"> (.) </span> er we thought in testing <span class="pause"> (.) </span> in <span class="pause"> (.) </span> in the next investigations we did <span class="pause"> (.) </span> to more systematically <span class="pause"> (.) </span> implant <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> not on the other level of the hippocampus <span class="pause"> (.) </span> but also <span class="pause"> (.) </span> and the basal temporal structure <span class="pause"> (.) </span> exploring with this multi- <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxxxxxx <span class="un_tag">&lt;/un&gt;</span></span><span class="pause"> (.) </span> the <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> entorhinal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> cortex and the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxxx <span class="un_tag">&lt;/un&gt;</span></span> cortex you know that it is a <span class="pause"> (.) </span> key structures <span class="pause"> (.) </span> for the input and <span class="emph"> OUT</span>put of the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> hippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> formations <span class="pause"> (2) </span> and er <span class="pause"> (.) </span> for example? you know that <span class="pause"> (.) </span> er <span class="pause"> (.) </span> we have er done <span class="pause"> (.) </span> some works? on <span class="pause"> (.) </span> the concept of <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epileptogenic <span class="pvc_tag"> &lt;/pvc&gt; </span></span> network </span></div>
         
         
         <div class="gap">(gap 00:07:38) <span>{mon; S12 continues talking about his findings}</span></div>
         
         
         <div class="u " id="PRpan585_u_106"><span class="line_no">PRpan585:106</span><span class="sid " id="src_PRpan585_u_106_PRpan585_S12">S12: </span><span class="utext"> in the brain stem which is a frame <span class="pause"> (.) </span> close to the to the target <span class="pause"> (.) </span> so it's also <span class="pause"> (.) </span> a constraint but which can be  (interesting)  in practice and <span class="pause"> (.) </span> you know i show you some preliminary result  but which are indicative perhaps interesting for the future <span class="pause"> (.) </span> and in this patient <span class="pause"> (.) </span> er what er this gamma knife in <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> er  (aid)  and <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> this is evolution <span class="pause"> (.) </span> you see <span class="pause"> (.) </span> of the seizure and <span class="pause"> (.) </span> of er the different <span class="pause"> (.) </span> parameters <span class="pause"> (.) </span> you have to see that sometimes you have an <span class="pause"> (.) </span> increase of the auras before <span class="pause"> (.) </span> the  (arrest)  of the seizures <span class="pause"> (.) </span> this er er patient <span class="pause"> (.) </span> you see the lesion is clearly <span class="pause"> (.) </span> er <span class="pause"> (.) </span> on to and be:hind all <span class="pause"> (.) </span> so <span class="pause"> (.) </span> there is a <span class="pause"> (.) </span> also <span class="pause"> (.) </span> other cases <span class="pause"> (.) </span> interesting <span class="pause"> (.) </span> this case after a <span class="pause"> (.) </span> real s- er <span class="pause"> (.) </span> true <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> (surgerist) <span class="pvc_tag"> &lt;/pvc&gt; </span></span> under surgery <span class="pause"> (.) </span> but it was a failure <span class="pause"> (.) </span> so the patient <span class="pause"> (.) </span> did not er <span class="pause"> (.) </span> choose to be real <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> (preferring your)  surgery <span class="pause"> (.) </span> we could complete <span class="pause"> (.) </span> er the <span class="pause"> (.) </span> operation on: the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> mesiotemporal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> structures that <span class="pause"> (.) </span> could be  (very interesting)  situation <span class="pause"> (.) </span> and so the <span class="pause"> (.) </span> we have also the hope?<span class="pause"> (.) </span> to perform <span class="pause"> (.) </span> a er true <span class="pause"> (.) </span> er er <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> mesiotemporal <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> operation in  (<span class="spel_tag">&lt;spel&gt;</span>m t l e<span class="spel_tag">&lt;/spel&gt;</span>)  in those patients with fo:r personal reason do not make the choice <span class="pause"> (.) </span> of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> x <span class="un_tag">&lt;/un&gt;</span></span> surgery <span class="pause"> (.) </span><span class="emph"> ALSO </span> for <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> neuropsy- -psychological <span class="pvc_tag"> &lt;/pvc&gt; </span></span> reason <span class="pause"> (.) </span> so it seems to me that <span class="pause"> (.) </span> there could be rationale <span class="pause"> (.) </span> and er: er <span class="pause"> (1) </span> today we say <span class="pause"> (.) </span> at the light of for your data and the data of other groups <span class="pause"> (.) </span> the groups of  [last name5]  in  [place5]  also and also the group <span class="pause"> (.) </span> er of  [place6]  in the works by the  [name2]  group <span class="pause"> (.) </span> are encouraging to er consider the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> area <span class="pause"> (.) </span> as a way <span class="pause"> (.) </span> of intervening <span class="emph"> SOONER </span> for preventing seizures <span class="pause"> (.) </span> thank you  </span></div>
         
         <div class="u " id="PRpan585_u_107"><span class="line_no">PRpan585:107</span><span class="sid " id="src_PRpan585_u_107_PRpan585_SS">SS: </span><span class="utext"><span class="vocal">&lt;applauds&gt;</span></span></div>
         
         <div class="u " id="PRpan585_u_108"><span class="line_no">PRpan585:108</span><span class="sid " id="src_PRpan585_u_108_PRpan585_S1">S1: </span><span class="utext"> thank you very much <span class="pause"> (1) </span> now you <span class="pause"> (1) </span> you brought a new approach to <span class="pause"> (.) </span> our <span class="pause"> (.) </span> er surgical <span class="emph"> TE</span>chniques <span class="pause"> (.) </span> but i think the main point you want to emphasize is the <span class="pause"> (.) </span> target er <span class="pause"> (.) </span> point <span class="pause"> (.) </span> like right after doctor  [S8/last]  you also <span class="pause"> (.) </span> focused on the <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> parahippocampal <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> er: strategies <span class="pause"> (.) </span> any questions or?<span class="pause"> (.) </span> remarks to <span class="pause"> (.) </span> doctor  [S12/last]'s <span class="pause"> (.) </span> presentation?<span class="pause"> (3) </span> somewhat i may ask about the complications for example?<span class="pause"> (2) </span></span></div>
         
         <div class="u " id="PRpan585_u_109"><span class="line_no">PRpan585:109</span><span class="sid " id="src_PRpan585_u_109_PRpan585_S12">S12: </span><span class="utext"> er yes er in fact er <span class="pause"> (.) </span> there is not not many complications in the <span class="pause"> (.) </span> current series <span class="pause"> (.) </span> because the dose  have been decreased <span class="pause"> (.) </span> in the first patient <span class="pause"> (.) </span> there are some complication with <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxxx <span class="un_tag">&lt;/un&gt;</span></span> oedema <span class="pause"> (.) </span> it was controlled by <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> cortical <span class="pvc_tag"> &lt;/pvc&gt; </span></span> therapy but it is no more er <span class="pause"> (.) </span> e::r interesting cos er with the decrease of the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> there is no more er complication.<span class="pause"> (1) </span> the only i <span class="pause"> (.) </span> the only question <span class="pause"> (.) </span> is <span class="pause"> (.) </span> there is the qu- in the efficacy <span class="pause"> (.) </span> and it's efficacious <span class="pause"> (.) </span> if <span class="pause"> (.) </span> the indication is good? if you have a true <span class="pause"> (.) </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> mesiotemporal <span class="pvc_tag"> &lt;/pvc&gt; </span></span> lobe <span class="pause"> (.) </span> epilepsy <span class="emph"> LIMITED </span><span class="pause"> (.) </span> to this structure <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> you know there are other types <span class="pause"> (.) </span> of temporal lobe epilepsy <span class="pause"> (.) </span> who  extend in the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> or lateral cortex <span class="pause"> (.) </span> in these <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> epilepsies <span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span> it's <span class="emph"> NOT </span> successful.<span class="pause"> (.) </span><span class="overlap"><span class="overlap_tag">&lt;3&gt;</span> so <span class="overlap_tag 3">&lt;/3&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_110"><span class="line_no">PRpan585:110</span><span class="sid " id="src_PRpan585_u_110_PRpan585_S1">S1: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;3&gt;</span> do <span class="overlap_tag 3">&lt;/3&gt;</span></span> we have any clues <span class="pause"> (.) </span> to identify these patients other than <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> electrophysiology?<span class="pvc_tag"> &lt;/pvc&gt; </span></span><span class="pause"> (.) </span><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span> like <span class="overlap_tag 4">&lt;/4&gt;</span></span> seizure <span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> semiology <span class="pvc_tag"> &lt;/pvc&gt; </span></span> or the <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> in the history?</span></div>
         
         <div class="u " id="PRpan585_u_111"><span class="line_no">PRpan585:111</span><span class="sid " id="src_PRpan585_u_111_PRpan585_S12">S12: </span><span class="utext"><span class="overlap"><span class="overlap_tag">&lt;4&gt;</span><span class="vocal"> @ </span><span class="overlap_tag 4">&lt;/4&gt;</span></span></span></div>
         
         <div class="u " id="PRpan585_u_112"><span class="line_no">PRpan585:112</span><span class="sid " id="src_PRpan585_u_112_PRpan585_S12">S12: </span><span class="utext"> yes you know my er er <span class="pause"> (1) </span> when i arrived in  [place7]  and i could work with  [first name4]  [last name4]  on this type of approach <span class="pause"> (.) </span> i i <span class="pause"> (.) </span> began my provocative attitude to say if we <span class="pause"> (.) </span> n- need to know? which are the good candidates <span class="pause"> (.) </span> and to demonstrate that this technique is accur<span class="emph">A</span>te <span class="pause"> (.) </span> you must implant electrodes <span class="pause"> (.) </span> to have a <span class="emph"> INVASIVE </span><span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> pre-surgical <span class="pvc_tag"> &lt;/pvc&gt; </span></span> er strategy <span class="pause"> (.) </span> before <span class="pause"> (.) </span> a non-invasive surgery if i can say <span class="pause"> (.) </span> to be sure with <span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xx <span class="un_tag">&lt;/un&gt;</span></span> electrodes <span class="pause"> (.) </span> that your epilepsy is limited to the to this areas <span class="pause"> (.) </span> it was our  first attitude <span class="pause"> (.) </span> but second <span class="pause"> (.) </span> you know it's: sometimes difficult to <span class="pause"> (.) </span> propose to  patients <span class="pause"> (.) </span> that <span class="pause"> (.) </span> er a strategy so now <span class="pause"> (.) </span> our criterion are <span class="pause"> (.) </span><span class="unintelligible"><span class="un_tag">&lt;un&gt;</span> xxx <span class="un_tag">&lt;/un&gt;</span></span> er  <span class="spel_tag">&lt;spel&gt;</span> e e g  <span class="spel_tag">&lt;/spel&gt;</span> er  (imagine)  techniques <span class="pause"> (.) </span> e::r and all all the <span class="pause"> (.) </span> all er the:<span class="pause"> (.) </span> criteria you can use <span class="pause"> (.) </span> by <span class="emph"> YOUR</span>self <span class="pause"> (.) </span> pet scan et cetera <span class="other_continuation"> = </span></span></div>
         
         <div class="u " id="PRpan585_u_113"><span class="line_no">PRpan585:113</span><span class="sid " id="src_PRpan585_u_113_PRpan585_S1">S1: </span><span class="utext"><span class="other_continuation"> = </span><span class="smode">&lt;soft&gt;</span> mhm <span class="pause"> (.) </span> okay <span class="smode">&lt;/soft&gt;</span><span class="pause"> (1) </span> okay thank you very much er i want to thank to  all the er participants and all the audience and for your patience and attendance
               of the s- <span class="pause"> (.) </span> session <span class="pause"> (.) </span> and as you've said you can be optimistic about our patients for the future but we have to wait for a <span class="pause"> (.) </span> for a while maybe <span class="pause"> (.) </span> but still there is the hope <span class="pause"> (.) </span> for the:<span class="pvc"><span class="pvc_tag"> &lt;pvc&gt; </span> curation <span class="pvc_tag"> &lt;/pvc&gt; </span></span> of the: severe epilepsy thank you </span></div>
         
         <div class="u " id="PRpan585_u_114"><span class="line_no">PRpan585:114</span><span class="sid " id="src_PRpan585_u_114_PRpan585_SS">SS: </span><span class="utext"><span class="vocal">&lt;applauds&gt;</span></span></div>
         
         
         
      </div>
   </body>
</html>